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that thymic settling is briefly CCR7/CCR9-independent after BMT but continues to rely on the selectin
ligand PSGL-1. The CCR7/CCR9 independence is transient, and by 3 weeks after BMT these receptors are
again strictly required. We next examine homing of progenitors to the thymus using an assay in which we
analyze the thymus for donor-derived thymocytes as early as 22 hours. For unirradiated mice, we
determined that LMPP and CLP can each directly home to the thymus. Surprisingly, following irradiation
conditioning, we find homing to the thymus decreases more than 10-fold. Concurrently, an important
chemokine ligand for thymic homing, CCL25, is greatly reduced on endothelium. Finally, we show that
pretreatment of bone marrow progenitors with CCL25 and CCL21 partially restores homing to the thymus
after irradiation conditioning and promotes T cell reconstitution.
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ABSTRACT
UNDERSTANDING T CELL RECOVERY FOLLOWING THYMUS
INJURY
Shirley L. Zhang
Avinash Bhandoola
T-cell production depends on the recruitment of hematopoietic progenitors into the
thymus. T cells are among the last of the hematopoietic lineages to recover after bone
marrow transplantation (BMT), but the reasons for this delay are not well understood. We
have found that rare bone marrow progenitors that can efficiently repopulate the thymus
are poorly reconstituted for at least 4 weeks and intrathymic progenitor niches remain
unsaturated for at least 10 weeks after BMT. In the following studies, we show that
thymic recovery is limited by the number of progenitors entering the thymus after BMT.
Under normal physiologic conditions, thymic settling is selective and either CCR7 or
CCR9 is required for progenitor access into the thymus. The mechanisms of early thymic
reconstitution after BMT, however, are unknown. Here we report that thymic settling is
briefly CCR7/CCR9-independent after BMT but continues to rely on the selectin ligand
PSGL-1. The CCR7/CCR9 independence is transient, and by 3 weeks after BMT these
receptors are again strictly required. We next examine homing of progenitors to the
thymus using an assay in which we analyze the thymus for donor-derived thymocytes as
early as 22 hours. For unirradiated mice, we determined that LMPP and CLP can each
directly home to the thymus. Surprisingly, following irradiation conditioning, we find
homing to the thymus decreases more than 10-fold. Concurrently, an important
chemokine ligand for thymic homing, CCL25, is greatly reduced on endothelium.
Finally, we show that pretreatment of bone marrow progenitors with CCL25 and CCL21
partially restores homing to the thymus after irradiation conditioning and promotes T cell
reconstitution.
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1.

CHAPTER I: INTRODUCTION
T lymphocytes are important in the adaptive immune response against pathogens, while
preventing inappropriate immune response to self (Stritesky et al., 2012). The primary
site of all T cell development is the thymus, which develops in the fetus from
mesenchymal cells and epithelial cells that attract immature lymphocyte precursors
(Anderson et al., 1993). T cell development begins in the fetus and continues throughout
adulthood. In adults, T cells originate from bone marrow progenitors that egress from the
bone marrow, traffic through the blood, and are imported into the thymus (Donskoy and
Goldschneider, 1992). Entry of progenitors into the thymus is regulated by the interaction
of molecules on the surface of lymphoid precursors with ligands and receptors on the
endothelial layer of blood vessels of the thymus. Progenitor cells immigrating to the
thymus receive signals to divide, differentiate, and commit to the T cell fate. The T cell
receptor (TCR) loci are recombined, and developing cells undergo positive and negative
selection based on the specificity of their TCRs (Morris and Allen, 2012). Several
lineages of T cells mature in the thymus, including γδ T cells, and subsets of αβ T cells
including NK-T cells, CD4 helper cells and CD8 cytotoxic T cells. Finally, the matured T
cells are released from the thymus into the periphery (Weinreich and Hogquist, 2008).
Production of naïve T cells is maintained by the thymus through life (Storek et al., 2003).
This chapter summarizes the current understanding of progenitor trafficking to the
thymus, which in adult mice involves progenitors exiting the bone marrow, traveling
though the circulation, homing to the thymus, and surviving in the thymic settling
progenitor niche. We first discuss the progenitors that are the likely thymic settling
progenitors that ultimately give rise to T cells. We address the mechanisms known to be
involved in bone marrow egress to the circulation and homing to the thymus in the adult
and the fetus. Most of what is known about thymic settling has been established in mice;
however, molecules implicated in thymic homing in mice have orthologues that are
required for T cell development in other model species including zebrafish and medaka,
suggesting that thymic homing is similar not only among mammalian species, but also in
other vertebrates (Boehm et al., 2003).
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Finally, we review potential clinical applications of modulating the process of thymic
settling in order to improve the regeneration of T cells. Following bone marrow
transplant (BMT), the T cell compartment is slow to reconstitute, leaving patients
immunocompromised (van Den Brink et al., 2013). Several aspects of T cell development
are impacted by BMT; we discuss whether aberrant thymic settling may contribute to
slower reconstitution.
1.1. Candidate thymic settling progenitors in the bone marrow
T cell potential is broadly distributed among primitive hematopoietic progenitor
populations; many distinct progenitors can become T cells. Among these, a more
restricted group of thymic settling progenitors also possesses the ability to mobilize from
the blood and enter the thymus. The experimental systems used to study progenitor
populations that settle the thymus involve intravenous transfers of large quantities of
progenitors that can be recovered at early time points, but may not reflect physiological
levels of progenitors in the blood. An additional complication is that the transferred cells
may not settle the thymus immediately, but may first differentiate into distinct cells that
then settle the thymus (Perry et al., 2006; Porritt et al., 2004; Schwarz and Bhandoola,
2004; Serwold et al., 2009). All of the progenitors described below have T cell potential,
as they will differentiate into T cells if placed in the thymus by intrathymic injection. The
characteristics of thymic settling progenitors have been discussed in detail in several
reviews (Bhandoola et al., 2007; Boehm and Bleul, 2006; Iwasaki and Akashi, 2007;
Izon, 2008; Koch and Radtke, 2011; Zlotoff and Bhandoola, 2011).
During fetal development, hematopoiesis occurs primarily in the liver, whereas in adults,
candidate thymic settling progenitors reside within the bone marrow (Mikkola and Orkin,
2006). Hematopoietic progenitors are functionally and phenotypically heterogeneous, and
can be distinguished by self-renewal capacity, lineage potential, and combinations of
surface markers. Hematopoietic stem cells (HSC) are the precursor cells from which all
blood cell types, including T cells, originate. HSC have the ability to self-renew and
2

continuously give rise to all blood cell types throughout the lifetime of the organism
(Osawa et al., 1996; Spangrude et al., 1988). HSC develop via non-renewing progenitor
intermediates into terminally differentiated blood cells, which have lost the potential to
differentiate into any other lineages. Phenotypically, HSC are negative for all lineage
markers and have high levels of Kit and Sca1 expression (LSK, for Lineage-negative,
Sca1+ Kit+) (Table 1.1).
HSC give rise to multipotent progenitors (MPP), which can also reconstitute all blood
lineages, but cannot self-renew (Adolfsson et al., 2001). MPP
share the LSK phenotype with HSCs, but can be separated from HSC by surface
expression of the cytokine receptor Flt3, among other markers (Christensen and
Weissman, 2001; Morrison et al., 1997; Wilson et al., 2008). MPP subsequently give rise
to a subset of cells termed lymphoid-primed multipotent progenitors (LMPP), which are
the highest Flt3-expressing LSK population. LMPP are also termed earliest lymphocyte
progenitors (ELP) due to the expression of early lymphoid genes such as Recombination
Activating Gene 1 (RAG1) and RAG2 (Igarashi et al., 2002). These cells retain myeloid
and lymphoid potential, but no longer possess megakaryocyte or erythroid potential
(Adolfsson et al., 2005).
Common lymphoid progenitors (CLP) differentiate from LMPP, accompanied by downregulation of expression of Kit and Sca1, retention of high Flt3 expression, and the
expression of high levels of surface IL-7 receptor (Kondo et al., 1997). CLP have
lymphoid potential but greatly attenuated myeloid potential (Kondo et al., 1997). CLP are
heterogenous, and can be further subdivided into the more primitive Ly6D- CLP and
downstream Ly6D+ CLP that also highly express RAG genes (Inlay et al., 2009; Mansson
et al., 2011). Cells further downstream of Ly6D+ CLP primarily produce B cells if they
are retained in the bone marrow.
The rapid kinetics with which intravenously transferred LMPP and CLP develop into T
cells suggest that physiological thymic settling progenitors are among these populations
3

(Schwarz et al., 2007). Upstream populations such as HSC produce T-lymphocytes with
greatly delayed kinetics in comparison to LMPP and CLP, suggesting these upstream
progenitors may home to the bone marrow prior to generating cells able to settle the
thymus. In spite of these advances, the precise identity of the cells that traffic to the
thymus has remained controversial (Allman et al., 2003; Martin et al., 2003; Porritt et al.,
2004; Serwold et al., 2009). A method of narrowing down the pool of potential thymic
settling progenitors is to determine the molecular requirements for trafficking from the
bone marrow to the circulation and migration from the circulation to the thymus. The
cellular machinery required for trafficking is only expressed on specific progenitor
populations. As discussed later, this approach indicates that physiological thymus settling
progenitors likely reside within LMPP and CLP subsets.
1.2. Mobilization into the circulation
In order for adult bone marrow-derived progenitors to arrive at the thymus, progenitors
with T lineage potential must first mobilize out of the bone marrow and into the blood.
Cells with progenitor phenotypes have been detected in peripheral blood at low levels.
Transfers of blood provide long-term multi-lineage reconstitution in recipients, indicating
that functional HSCs circulate (Goodman and Hodgson, 1962; Schwarz and Bhandoola,
2004; Wright et al., 2001). MPP, LMPP, and CLP have been detected in the blood;
however the very low number of progenitors in the circulation of adult mice has made it
difficult to study the physiological regulation of bone marrow progenitor migration (Lai
and Kondo, 2007; Perry et al., 2006; Schwarz and Bhandoola, 2004). For this reason, the
signals that may govern physiological mobilization, if any, are largely unknown.
However, there are pharmacological methods of mobilizing progenitors to the blood,
which have suggested possible mechanisms of retention and egress. Exogenous
administration of several cytokines and hormones, described below, can induce
progenitor release from the bone marrow.
Bone marrow progenitors reside in localized niches along perivascular sites at the
endosteum of the bone (Kunisaki and Frenette, 2012). Many cells of the bone marrow are
4

thought to support the HSC niche including osteoblasts, perivascular mesenchymal stem
cells, and sinusoidal endothelial cells (Lymperi et al., 2010). Mesenchymal stem cells
express adhesion molecules and chemokines, which retain and maintain hematopoietic
progenitors within the bone marrow (Mendez-Ferrer et al., 2010). Vascular cell adhesion
molecule 1 (VCAM-1) tethers stem and progenitor cells to the bone (Simmons et al.,
1992). The chemokine receptor CXCR4 and its ligand CXCL12, also known as stromal
cell derived factor-1, have been suggested to regulate the retention of progenitors
(Pitchford et al., 2009). Blockade of CXCR4 through administration of an antagonist,
AMD3100, allows for rapid mobilization of bone marrow progenitors into the blood.
Other chemokines have been reported to mobilize progenitor cells into the circulation,
including CCL3 (MIP-1α), CXCL8 (IL-8), and CXCL2 (GRO-β) (King et al., 2001;
Marshall et al., 1997; Pruijt et al., 2002).
Erythropoietin, thrombopoietin, and granulocyte colony-stimulating factor (G-CSF) have
each been found to induce bone marrow progenitor mobilization (Murray et al., 1998;
Pettengell et al., 1994). G-CSF is widely used clinically to mobilize stem and progenitor
cells for transplants. The response of HSC mobilization to G-CSF is more sustained than
the response to AMD3100, although the effects of both therapies are transient. G-CSF is
thought to act on the bone marrow niche through macrophage and neutrophil-mediated
release of cytokines and metalloproteases that degrade the extracellular matrix (Liu et al.,
2000; Pelus et al., 2004; Winkler et al., 2012). G-CSF has also been found to disrupt
CXCL12 expression (Levesque et al., 2003; Petit et al., 2002). G-CSF and AMD3100 act
synergistically to mobilize bone marrow progenitors (Broxmeyer et al., 2005).
More recently, sphingosine-1 phosphate (S1P) gradients have been found to be important
in mediating progenitor egress from the bone marrow (Golan et al., 2012). When S1P
receptors are inhibited with FTY720, hematopoietic progenitors are prevented from
leaving the bone marrow and entering into the circulation. Furthermore, blockade of
CXCR4 or administration of G-CSF has been found to upregulate S1P in blood plasma,
which then facilitates progenitor egress (Golan et al., 2012; Ratajczak et al., 2010).
5

Together these data suggest a model in which competing chemokine gradients favor
either retention or mobility and thus regulate the rate of progenitor egress from the bone
marrow (Figure 1.2). This model would imply that at homeostasis, most progenitors in
bone marrow receive more retention signals than mobilizing signals, but specific
populations of progenitors may egress the bone marrow through the regulated control of
their retention or mobilization molecules. Another possibility is that small numbers of
progenitors randomly escape from the bone marrow into the blood. This latter hypothesis
would be supported by equivalent relative ratios of different progenitor populations in the
blood and the bone marrow.
1.3. Entering the thymus
1.3.1 The molecular basis of homing
Settling of the thymus by hematopoietic progenitors in adult mice is thought to be a rare
event, and fewer than 20 cells per day have been estimated to lodge within the thymus
(Wallis et al., 1975). This estimate is based on intravenous injection of a mixture of two
bone marrow populations bearing congenic markers into irradiated mice. When the
thymus of these mice was examined later, there was considerable variation in the ratio of
the congenic markers expressed on thymocytes in different mice. Although this
experiment involved radiation and is not the physiological condition, it indicates that the
number of thymic settling progenitors can be very low. If this is also true in physiological
conditions, this can help explain why it has been so difficult to identify progenitors
within the thymus that have properties and surface phenotype identical to bone marrow
populations.
The earliest defined T cell precursor population in the thymus are termed early thymic
progenitors (ETP), which have been characterized as negative/low for CD4 and CD8
coreceptors, positive for CD44 and Kit, but have not yet upregulated CD25 (DN1 Kit+)
(Allman et al., 2003; Benz et al., 2008; Porritt et al., 2004; Shortman and Wu, 1996). The
6

phenotype of the thymic settling progenitors has been shown to rapidly change once they
enter the thymus and are exposed to Notch ligands (Krueger et al., 2006). Since putative
rare upstream progenitors cannot yet be identified or analyzed directly, the
characterization of ETP has been used to deduce the properties of thymic settling
progenitors. As progenitor cells differentiate, developmental potentials for non-T-cell
lineages are lost; therefore, the more primitive thymic settling progenitors are those that
have the same or more lineage potentials than ETP. ETP are not committed to the T cell
lineage and subsets of ETP retain B cell, NK cell, dendritic cell, and a degree of myeloid
potential (Bell and Bhandoola, 2008; Luc et al., 2012). Some ETP adopt a granulocyte
fate within the thymus, providing support for the idea that some thymic settling
progenitors are myelo-lymphoid progenitors (De Obaldia et al., 2013; Luc et al., 2012).
Homing of progenitors to the thymus has been suggested to be similar to lymphocyte
homing to lymph nodes, a process which involves selectin ligands, chemokine receptors
and integrins (Scimone et al., 2006). In this model, progenitors are thought to undergo a
multistep cascade, which includes: rolling adhesion; chemoattraction; tight adhesion; and
transendothelial migration. L-selectin on T lymphocytes mediates rolling adhesion by
binding to peripheral node addressin (PNAD) on the surface of endothelial cells.
Expression of surface CCR7 allows lymphocytes to migrate towards the chemokine
ligand CCL21, which is found on high endothelial venules. Signaling though the
chemokine receptor activates integrins to acquire a high affinity structure. Integrin
binding arrests the cell and additional signals induce transmigration of the cell through
the endothelial layer into the lymph nodes (Springer, 1994). In trafficking to the thymus,
P-selectin glycoprotein ligand 1 (PSGL-1) and CCR7 or CCR9 on hematopoietic
progenitors interact with targets on the endothelium for migration into the tissue (Krueger
et al., 2010; Rossi et al., 2005b; Scimone et al., 2006; Zlotoff et al., 2010).
PSGL-1 is an important molecule present on bone marrow progenitors involved in
homing to the thymus (Rossi et al., 2005b; Sultana et al., 2012). The receptor for PSGL-1
is P-selectin, which is present on the surface of some endothelial cells lining the
vasculature of the thymus (Rossi et al., 2005b). Periodic alterations in levels of P7

selectin on thymic endothelial cells are suggested to regulate the receptivity of the
thymus to progenitors (Gossens et al., 2009). Progenitors deficient in PSGL-1 are
inefficient at generating thymocytes in competition with wild-type progenitors; however,
there is no deficiency in bone marrow progenitor generation (Rossi et al., 2005b).
Although all bone marrow progenitors express PSGL-1 transcripts, expression of
functional protein able to bind P-selectin requires post-translational modifications via
sialyation, glycosylation, and sulfation (Li et al., 1996). Expression of functional PSGL1 is low in HSCs and MPPs, but upregulated on downstream CCR9+ LMPP and Ly6DCLP. Additionally, transcripts for glycosyltransferase enzymes Fut4 and Fut7, which are
required for functional PSGL-1 expression, are most abundant in LMPP and Ly6D- CLP,
and progenitors lacking Fut4 and Fut7 did not efficiently home to the thymus (Sultana et
al., 2012).
The involvement of chemokine receptors in thymic homing was suggested by pertussis
toxin blockade of G protein couple receptor (GPCR). Pertussis toxin treatment of bone
marrow progenitors prior to intravenous transfer diminishes ETP numbers in the thymus,
indicating that Gαi signaling in bone marrow progenitors is required for thymic homing
(Jin and Wu, 2008). The guanine nucleotide exchange factors (GEFs) involved in homing
to the fetal thymus are DOCK2 and DOCK180. DOCK2 and DOCK180 double deficient
mice have a smaller fetal thymus and progenitor cells lacking DOCK2 and DOCK180 are
defective in in vitro migration to fetal thymic lobes; however, mutant progenitors were
capable of producing T cells when cocultured on a fetal thymic stroma (Lei et al., 2009).
Together, these results suggest that one or more receptors for chemoattractants (which are
generally GPCRs) might be important in thymic homing.
Indeed, the chemokine receptors CCR7 and CCR9 have been implicated in thymic
homing in fetal and adult mice (Krueger et al., 2010; Liu et al., 2006; Uehara et al., 2002;
Zlotoff et al., 2010). The ligands for CCR7 and CCR9, which are CCL21/CCL19 and
CCL25 respectively, are produced by stromal epithelial cells in the thymus (Ciofani and
Zuniga-Pflucker, 2007). CCL25 is expressed by all thymic epithelial cells (TEC) whereas
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CCL19 and CCL21 are expressed by medullary epithelial cells (Misslitz et al., 2004;
Ueno et al., 2004; Wurbel et al., 2000). CCL25 is also found in the small intestine,
whereas CCL21 is expressed in a wide range of organs (Vicari et al., 1997; Willimann et
al., 1998). When progenitors deficient for either CCR7 and/or CCR9 are placed in
competition with wild-type cells using mixed bone marrow irradiation chimeras, the
knockout cells contribute less efficiently to thymic and peripheral T cell lineages;
however, hematopoietic progenitor development in the bone marrow is largely
unaffected. The defect is overcome when the cells are transferred directly to the thymus
by intrathymic injection (Krueger et al., 2010; Schwarz et al., 2007; Zlotoff et al., 2010).
These data together indicate that most efficient progenitor homing relies on CCR7 and
CCR9. Other chemokines such as CXCR4 and CCR5 might also have a role in progenitor
migration; however, the relative contribution of these receptors to homing in adult mice
needs to be further evaluated (Robertson et al., 2006).
Integrins are thought to be responsible for mediating firm adhesion of rolling progenitors
in the vasculature of the thymus (Ruiz et al., 1995). CLP express high levels of αLβ2 and
α4β1 integrins, which bind the receptors ICAM-1 and VCAM-1 that are expressed by
thymic endothelial cells. Inhibition of integrins on bone marrow progenitors transferred
intravenously reduced trafficking to the thymus, suggesting that these integrin pairs play
a role in homing (Scimone et al., 2006).
Although thymic settling progenitors have not been unambiguously identified, the
available evidence implicates cells that express CCR9 or CCR7 (or both), functional
PSGL-1, and integrins. HSC and MPP do not express either CCR9 or CCR7, eliminating
them as efficient thymic homing progenitors. A subset of common myeloid progenitors
possesses a degree of T cell potential in addition to myeloid potential; however, absence
of CCR7 or CCR9 expression implies that normally these cells do not contribute to T
lymphopoiesis (Chi et al., 2010). CCR9 and CCR7 are expressed on subsets of LMPP,
and nearly all CLP express CCR7 and some also express CCR9. Furthermore, functional
PSGL-1 is most highly expressed on CCR9+ LMPP and Ly6D- CLP (Sultana et al.,
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2012). The gene expression profile and lineage potential of ETP have been found to be
similar to CLP and LMPP (Luc et al., 2012). Together these data narrow down the
competent thymic settling progenitors to subsets of LMPP and/or CLP; although their
relative contributions towards T cell development are not known with certainty.
1.3.2 The thymic settling progenitor niche
Although the precise identities of the progenitor cells have been elusive, several
characteristics of the thymic settling progenitor niche are known. Thymic settling has
been suggested to be a “gated” phenomenon. Progenitors settling the thymus are thought
to initially occupy niches that only become vacant when these progenitors further
differentiate, resulting in periodic waves of thymic entry (Donskoy et al., 2003). The few
thymic settling progenitors that have been found have been imaged at the corticomedullary junction (CMJ) where there are large, postcapillary venules (Lind et al., 2001).
This suggests that the thymus settling progenitor niche might be located adjacent to the
CMJ (Porritt et al., 2003). Due to the difficulty of studying the cells directly, the number
of thymic settling progenitors residing in the niche remains unclear; however, an early
estimate was provided by intrathymic injections of HSCs. Approximately 200 HSCs are
sufficient to maintain the production of T cells (Spangrude and Scollay, 1990). More
recently, it was shown that HSC injected into the thymus of ZAP70-deficient mice
(which have a block at the CD4/CD8 double positive stage of development) are able to
sustain T cell differentiation for considerably longer than physiological thymus settling
progenitors (Adjali et al., 2005). Because HSC are more efficient in producing
thymocytes than cells that normally settle the thymus, 200 cells is likely to be an
underestimate of the size of the niche. Intrathymic transplants of total bone marrow
progenitors in ZAP70-deficient mice increased the number of ETP, indicating that this
progenitor niche within the thymus is either unsaturated or can be expanded (Vicente et
al., 2010). The transplanted cells that engraft the thymus after intrathymic injection of
bone marrow progenitors are unable to maintain long-term multilineage hematopoiesis on
secondary intravenous transplant (Vicente et al., 2010). Hence, the progenitor niche
within the thymus does not support the self-renewal of bonafide HSC.
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When fetal thymi are transplanted into mice with competent progenitor populations in
bone marrow, resident thymocytes are substituted within four weeks by the progeny of
incoming progenitors (Berzins et al., 1998). This observation had suggested that
progenitors residing within the thymus were non-renewing and a constant supply of
progenitors imported from the blood was required to maintain progenitors in the thymus,
and sustain long-term T cell development. However, recent studies have used thymic
transplants into mice lacking the common gamma chain cytokine receptor, or lacking IL7Rα. In these circumstances, T cell development is sustained on the order of months,
much longer than had been previously suggested (Martins et al., 2012; Peaudecerf et al.,
2012). These surprising findings indicate that normally, the incoming cells to the
progenitor niche force out resident cells based on competition for IL-7 and possibly other
growth or differentiation factors such as Flt3 and Notch ligands. In the absence of
competition for the niche, progenitors in the thymus can renew the early thymocyte
populations for a prolonged period. These data alter our understanding of self-renewal of
progenitor populations. Self-renewal ability may not be unique to stem cells, but may
depend on whether progenitor cells can compete for relevant niches.
1.4. Fetal versus adult thymic settling
Hematopoiesis in the mouse embryo differs from that in the adult. Primitive
hematopoietic cells first appear in the yolk sac, but these early progenitors do not
generate lymphocytes. Early lymphopoiesis appears to arise independently from HSCs
(Yokota et al., 2006). Such “spontaneous” lymphopoiesis occurs at embryonic day 8.5;
HSCs with lymphoid potential do not emerge from the aortogonad-mesonephros (AGM)
region until embryonic day 10.5 (Li et al., 2012; Muller et al., 1994). The main source of
hematopoiesis during the remainder of fetal life is the liver (Christensen et al., 2004).
A thymus-parathyroid primordium forms out of the third pharyngeal pouch at embryonic
day 9.5;	
   however, the thymic rudiment does not receive an influx of progenitors until
embryonic day 10.5 (Hilfer and Brown, 1984). Lymphoid progenitors are recruited to the
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area surrounding the thymic rudiment and are encapsulated within the thymus by
approximately embryonic day 12.5 (Jotereau et al., 1987). In the fetal liver, there are
well-characterized progenitors that are restricted to T/NK/DC lineages that do not possess
B or myeloid cell potential (Kawamoto et al., 2000). These cells express paired
immunoglobulin receptor (PIR) and can also be found in the fetal blood and thymus
(Ikawa et al., 2004; Masuda et al., 2005). The early fetal T cell progenitors express high
levels of Kit and IL-7R and also appear to be restricted to the T/NK/DC lineage (Masuda
et al., 2005). This suggests that commitment to the T/NK/DC lineage may occur prior to
migration to the thymus in fetal mice. A prethymic T-lineage committed population has
also been found in adult mice (Dejbakhsh-Jones and Strober, 1999; Garcia-Ojeda et al.,
2005; Krueger and von Boehmer, 2007). It is unclear to what extent T-lineage restricted
progenitors contribute to thymopoiesis; progenitors settling the thymus may be a
heterogeneous population consisting of both lineage-restricted and multipotent cells
(Bhandoola et al., 2007; Rodewald et al., 1994).
Thymic homing in the fetus is initiated prior to the vascularization of the thymus
primordium. Therefore thymic settling has both prevascular and postvascular stages.
During the prevascular phase, chemotaxis is the key component regulating thymic
settling. As in the adult, chemokine receptors CCR7 and CCR9 are important to this
process (Liu et al., 2006). In addition, CXCR4 has been found to have redundant
functions with CCR7 and CCR9 in thymic homing to the prevascular thymus (Calderon
and Boehm, 2011). In the absence of CCR9, CCR7, and CXCR4, fetal liver progenitors
had a 100-fold decrease in thymic homing, whereas any of the double deficient
progenitors only had up to 10-fold decrease in thymic homing (Calderon and Boehm,
2011). After the fetal thymus vascularizes, thymic homing is thought to occur primarily
through the circulation (Dunon et al., 1999). Homing to the vascularized fetal thymus
remains dependent on the same three chemokine receptors but the requirement for other
molecules must appear so progenitors can migrate in the presence of blood flow
(Calderon and Boehm, 2011). The progenitors require adhesion molecules such as
selectins and integrins to slow the cells, to allow for transendothelial migration into the
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thymus. The trafficking molecules involved in homing to the vascularized fetal thymus
are likely to be similar to the molecules involved in the adult thymus; however, this has
not yet been confirmed.
Ephrins (Ephs) are molecules other than chemokines that have been shown to be involved
in thymic homing in the fetus (Stimamiglio et al., 2010). Ephs are receptor tyrosine
kinases which are essential for pattern formation during embryonic development
(Pasquale, 2008). EphB2 is expressed on bone marrow progenitors and progenitors
deficient in EphB2 exhibit decreased homing to the fetal thymus when in competition
with WT cells (Stimamiglio et al., 2010). Furthermore, thymi with TEC deficient in
EphB2 do not support normal colonization of progenitors, suggesting a non-cell
autonomous effect of EphB2 signaling in TEC on progenitors. In the adult thymus, Ephs
are important in many aspects of T cell development; however, more work is needed to
determine whether they are also involved in homing (Munoz et al., 2011).
There are several differences in thymopoiesis between the fetus and adult (Figure 1.3). In
fetal mice, there are much higher levels of progenitors in the fetal blood (Rodewald et al.,
1994). Fetal ETP constitute a larger percentage of thymocytes (Belyaev et al., 2012;
Hozumi et al., 2008). In adults, fewer progenitors are present in the blood and the ratio of
ETP to total thymocytes is lower. However, adult progenitors appear more than 100-fold
more efficient at expanding and giving rise to T cells when directly compared by
intrathymic injection ((Lu et al., 2005); see Figure 1.3). These differences suggest that
cells that settle the thymus are functionally distinct between fetal and adult stages. In fetal
mice, more progenitors may settle the thymus to become ETP, however these progenitors
have considerably less proliferative capacity than cells with similar phenotypes in adult
thymus. Perhaps consistently, gene expression analysis of fetal ETP suggests that they are
more similar to adult DN2 cells than adult ETP (Belyaev et al., 2012). Together these
data suggest that in the adult, increased proliferative ability can compensate for reduced
thymic settling.
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1.5. Regeneration of the T lineage
Regeneration of the immune system is an area of clinical interest particularly in immune
compromised patients as well as the elderly. Aging is characterized by changes in bone
marrow and thymus that contribute to functional decline in T cell production (Haynes and
Swain, 2006). Aged bone marrow hematopoietic progenitors lose T lineage potential
(Rossi et al., 2005a; Zediak et al., 2007). The architectural structure of the thymus
changes as evidenced by disorganization and reduced numbers of TEC (Flores et al.,
1999). All T cell progenitor subsets are present within the thymus, but in lower numbers
(Min et al., 2004). Total thymic cellularity is reduced, resulting in decreased thymic
output of naïve T cells (den Braber et al., 2012). In healthy individuals, it is not clear
whether maintaining continuous thymic output is necessary for immune protection;
however, reviving thymic function is clearly important for patients that have received
cyto-reductive therapies. (Hakim et al., 2005; Mackall et al., 1995).
One example where T cell regeneration is important is following bone marrow transplant
(BMT). BMT patients receive conditioning regimens including chemotherapy and/or
radiation therapy to severely deplete host hematopoietic cells. Donor cells eventually
reconstitute the patient’s hematopoietic cell compartments; however, T cells are usually
the last of the hematopoietic cell lineages to recover (Wils et al., 2011). This is the case
even in autologous transplants, in which patients receive their own bone marrow (Storek
et al., 2004a). Immune recovery after BMT is often characterized by a prolonged
reduction in total CD4+ T cell numbers that leave patients susceptible to infections,
correlating with higher rates of mortality (Berger et al., 2008; Small et al., 1999).
Following irradiation conditioning, peripheral T cells can be regenerated in several ways:
1) thymus-dependent development of naïve T cells 2) thymus-independent homeostatic
proliferation of donor and residual host mature T cells or 3) naïve T cells developing
extrathymically (Dulude et al., 1997; Miller et al., 1963). Thymus-independent T cell
regeneration results in skewed and limited TCR diversity, which is associated with
impaired immunity (Hsieh et al., 2012; Mackall et al., 1996; Yager et al., 2008). Thymusdependent T cell output can be measured by high levels of T cell receptor excision circles
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(TREC), which are by-products of V(D)J recombination (Douek et al., 1998). Higher
levels of thymic output before BMT, as determined by TREC levels, can predict the
success of T cell reconstitution and patient outcome (Chen et al., 2005; Svaldi et al.,
2003). In aged individuals who have impaired thymic function, another possible source of
naïve T cells are those that develop outside the thymus. This population of T cells was
found to develop in athymic nude mice after irradiation conditioning (Dulude et al.,
1997). These extrathymically developing cells have been shown to be functional;
however, in response to infections, these cells have limited proliferative ability and are a
poor substitute for cells derived from the thymus (Blais et al., 2004; Holland et al., 2012).
Several components of thymus-dependent T cell regeneration have been examined
following BMT: 1) production of thymic settling bone marrow progenitors, 2) trafficking
of the progenitors into the blood and thymus, and 3) the ability of intrathymic
environment to support T cell development. Each of these components of T cell
development has been found to contribute to the slow recovery of the T cell compartment
following BMT. The supply of lymphoid progenitors in the bone marrow is diminished,
indicating that the pool of potential thymic settling progenitors is reduced (Zlotoff et al.,
2011). Trafficking of progenitors into the thymus is a limiting aspect of T cell recovery
after BMT and increasing the number of T-cell precursors can enhance T-cell
reconstitution (Dallas et al., 2007; Zakrzewski et al., 2006; Zlotoff et al., 2011). For BMT
patients, the defects in both production of progenitors and trafficking to the thymus can
be remedied by increasing the number of T-cell competent progenitors that reach the
thymus. The intrathymic environment is altered post-BMT in part due to conditioning
regimens that deplete the thymus of cortical and medullary TEC (Chung et al., 2001;
Williams et al., 2009). Once T cell progenitors settle the thymus, their expansion can be
improved by growth factors and cytokines. Keratinocyte growth factor (KGF) protects
thymic epithelial cells from injury resulting from the conditioning regimens that precede
bone marrow transplantation (Kelly et al., 2008; Min et al., 2002). In both mice and
rhesus macaque models of BMT, administration of KGF was shown to improve
thymopoiesis and naïve T cell recovery (Alpdogan et al., 2006). In addition, the cytokine
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IL-22 has recently been shown to be important for TEC regeneration following BMT
(Dudakov et al., 2012). Other cytokines have been shown to affect lymphocyte
proliferation and survival after BMT. Providing lymphocytes with IL-7 and Flt3 ligand
can enhance both prethymic and intrathymic reconstitution. (Fry et al., 2004; Kenins et
al., 2008; Wils et al., 2007). Together, these data suggest that enhancing both lymphoid
and non-lymphoid tissues can improve regenerative efforts.
The aged thymus can also be regenerated though the ablation of sex steroids; however,
the increase in thymic size and naïve T cell output is only temporary (Olsen et al., 1991;
Roden et al., 2004; Weinberg et al., 2001). During sex steroid ablation (SSA)-induced
regeneration, thymic homing is improved through increased TEC production of CCL25
(Williams et al., 2008). Presently it is unclear whether the genes that dictate normal
thymic development and growth are the same as those that control regeneration after
SSA. Analysis of the regenerated thymus after SSA suggests that most gene pathways are
more similar to those of an old thymus rather than a young thymus (Griffith et al., 2011).
Gene expression analysis of the young and regenerated thymus would suggest that the
pathways governing initial thymic development and those that dictate regrowth may
involve two separate mechanisms. An alternate interpretation of these data is that there
are a small number of as yet unidentified shared pathways in both young and regenerated
thymi, which dictate thymic size and functionality. The latter possibility suggests that
patients who require improved thymic regeneration may benefit from the induction of
these pathways.
1.6 Discussion
Unlike other blood cells, T cells develop in a sequestered organ distant from the bone
marrow. This presents T cell precursors with the additional difficulty of trafficking out of
the bone marrow, through the blood, and entering the thymus. Many bone marrow
progenitors have the potential to become T cells, yet only a few subsets have the
necessary molecules to home to the thymus. These subsets are thought to be within the
more lymphoid biased LMPP and CLP populations.
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Although the identity of the thymic settling progenitors is becoming clearer, the logic
underlying the restriction of thymic homing ability to specific subsets of progenitor cells
is not fully understood. Progenitors with greater capacity to produce other blood lineages
given unrestricted entry to the thymus might give rise to progeny that compete with early
T cell precursors. In the adult, very low numbers of thymic settling progenitors indicate
that T lymphopoiesis is mainly driven by proliferative expansion. Why do so few
progenitors settle the thymus in adult mice? The small number of progenitors that home
to the thymus seems paradoxical as the redundancy of chemokines makes homing robust.
The absence of a single chemokine or even two chemokines does not abrogate thymic
homing entirely. In zebrafish and medaka, multiple chemokine receptors regulate thymic
homing (CCR9 and CXCR4) and more receptors have been implicated in the mouse
(CCR7, CCR9, and CXCR4). This redundancy suggests that either many different types
of progenitors could home to the thymus each via a separate chemokine receptor or that
one specific subset of progenitors can use any of several different chemokine receptors to
home to the thymus. As the pool of potential thymic settling progenitors is further
narrowed, these two possibilities might be differentiated.
Understanding the identity and properties of the thymic settling cells may contribute to
clinical treatments. For example, treating BMT patients with efficient thymic settling
progenitors in conjunction with treatments to improve intrathymic reconstitution may
help prevent delays in T lineage reconstitution.
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Figure 1.1 Candidate thymic settling progenitors
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CCR7, CCR9
PSGL-1
N/A

Figure 1.2 Model for bone marrow progenitor mobilization. Progenitors in the bone
marrow are retained by adhesion molecules such as VCAM-1 and the chemokine ligand
CXCL12. Mobilization can be mediated through the increase in cytokines and S1P in
blood or through G-CSF induced downregulation of CXCL12.
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Figure 1.3 Differences in T lymphopoiesis between late fetal and adult mice.
Progenitors with T cell potential are more abundant in fetal than adult blood. Fetal ETP
constitute a greater fraction of thymocytes and make fewer DP on a per cell basis.
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2. CHAPTER II: CHARACTERIZATION OF THE THYMIC SETTING
PROGENITOR
2.1 Introduction
T cell development in the thymus from bone marrow (BM) derived hematopoietic
precursors occurs through a series of well defined developmental stages. The thymus
provides a specialized microenvironment required for the differentiation and proliferation
of immature thymocytes (Goldschneider et al., 1986; Morrison et al., 1995; Scollay et al.,
1986). The thymus does not contain self-renewing T-lineage progenitors and therefore
requires continuous replenishment and recruitment of precursors from BM via circulation
(Donskoy and Goldschneider, 1992; Foss et al., 2002). The unknown cellular
phenotype(s) and extremely low frequency of thymus-seeding progenitors (TSPs) makes
the direct and precise characterization of these T-lineage progenitors difficult. The
identity of hematopoietic precursors, which home to the thymus under physiological
conditions is unclear, controversial, and remains the subject of investigation (Bhandoola
et al., 2007).
Experimentally, many BM stem and progenitor populations can give rise to T cells when
they are placed in the blood or directly in the thymus. These include hematopoietic stem
cell (HSC; Lin-Kit+Sca1+Flt3–), multipotent progenitor (MPP; Lin–Kit+Sca1+Flt3low),
lymphoid-specified MPP (LMPP; Lin–Kit+Sca1+Flt3high), and common lymphoid
progenitor

(CLP;

Lin-–KitlowSca1lowFlt3highIL-7R(+))

that

are

more

lymphoid

committed/restricted (Bhandoola et al., 2007; Sitnicka, 2009). Our lab previously
reported that thymus seeding is selective and HSC do not directly settle the thymus under
physiologic condition (Schwarz et al., 2007). HSC generate T cells with a significant
delay relative to MPP and CLP, consistent with indirect thymic colonization from HSC
via downstream progenitors. Current evidence suggests that all thymocyte precursor
activity resides mostly within the fms-related tyrosine kinase3 positive (Flt3+) subset of
BM, which includes MPPs and CLP (Karsunky et al., 2008; Serwold et al., 2009). Both
MPP and CLP were able to generate T cells in the thymus following i.v. transfer
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efficiently, whereas the remaining lineage-negative BM progenitors did not. CLP were
proposed to be a plausible T lineage precursor in part because they resemble ETPs in
many respects. CLP are able to generate every lymphoid lineage, are capable of adopting
an ETP phenotype rapidly (Bhandoola and Sambandam, 2006; Bhandoola et al., 2007).
However, the idea of CLP as T lineage progenitors has been challenged on the ground of
several observations. CLP are less efficient T lineage progenitors than ETPs and ikaros
mutant mice, which lack phenotypic CLP, exhibit intact thymopoiesis (Allman et al.,
2003). It has also been proposed that, unlike CLP, ETPs possess a substantial degree of
myeloid potential. There exists some experimental evidence that CLP have in vitro
myeloid potential (Schlenner et al.). A cluster of studies led to the alternative hypothesis
that MPPs could be the major source of thymic seeding cells. The similar cell surface
phynotypes and higher proliferation potential of ETPs and MPPs, compared to CLP, are
consistent with this idea (Bhandoola and Sambandam, 2006; Bhandoola et al., 2007;
Sitnicka, 2009). Two recent reports demonstrated the clonal myeloid potential of ETPs,
which again supports the popular view that MPPs are the most important physiologic T
lineage progenitors (Bell and Bhandoola, 2008; Wada et al., 2008). Recently, this
myeloid–based model was challenged by one report that suggested that T cells and
myeloid lineages in the thymus have separate origins (Schlenner et al.); however, this
point continues to be disputed. MPPs are a quite heterogeneous population and our lab
showed that most efficient thymus-settling progenitors within the MPP population are
LMPP (Flt3high MPP) (Schwarz et al., 2007). Another recent study also suggested that a
small Flt3high subfraction of MPP, which are also chemokine receptor CCR9 positive are
the immediate upstream precursors of ETPs (Lai and Kondo, 2007). Thus, despite
significant

progress

in

understanding

T

cell

lymphophoiesis

and

extensive

characterization of different BM and blood progenitors, it has been difficult to identify
direct seeding T lineage progenitor population(s).
On the road map of T cell lineage commitment and development, it is also unclear
whether there is only one T lineage precursor or whether there are multiple distinct T
lineage specific progenitors. Two recent reports sought to directly test for the
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predominant source of thymocyte progenitors in the BM. To exclude any progenitor
activity that was the result of differentiation of long term hematopoietic stem cells these
studies tested both MPP and CLP subsets for their ability to give rise to thymocytes over
a relatively short period of time (7-14 days). The results of one of these studies are
consistent with the CLP progenitor model of thymopoiesis, showing that among CLP
and MPP, only CLP reconstitute thymopoisis directly and rapidly after intravenous
injection (Serwold et al., 2009). In this study, MPP also gave rise to thymocytes at later
time point and such delayed development suggests that MPP proceeded through a
prethymic intermediate. Another study, using a competitive in vivo assay based on
depletion rather than enrichment of classes of BM derived precursors showed that both
MPP and CLP like subsets have robust T lineage potential (Saran et al.). Though these
two studies analyzed the thymus at early time points, it remains possible that these
progenitors either directly seed the thymus or they very rapidly seed another organ where
they generate a downstream precursors which goes on to seed the thymus and give rise to
thymocytes. Therefore, to address this issue, we used a short-term homing assay and
found that HSC and MPP do not directly settle thymus under physiological condition. We
identified only LMPP and CLP as the potential thymic homing precursors. We find that
the thymic settling progenitors are likely to be a heterogenous group of very small
number of cells within the LMPP and CLP populations.
2.2 Results
2.2.1 Establishing an assay to measure homing of progenitors to the thymus
Several hematopoietic progenitors have T lineage potential; however, only intravenously
injected LMPP and CLP rapidly generate intrathymic T cells whereas earlier precursors
such as multipotent HSC and MPP are delayed in differentiation (Schwarz et al., 2007).
Hence, LMPP and CLP may each contain the immediate T cell precursors that settle the
thymus, although the low frequency and unknown cellular phenotype(s) of thymic
settling progenitors makes the characterization of these T-lineage progenitors difficult
(Krueger et al., 2006; Schwarz et al., 2007; Serwold et al., 2009). Once progenitors enter
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the thymus, the cells are exposed to Notch ligands and differentiate into early thymic
progenitors (Lin-Kit+, ETP), the most primitive defined intrathymic T cell precursor
(Allman et al., 2003). To separate the ability of putative T lineage progenitors to home to
the thymus from later effects involving selective survival and proliferation, we measured
homing to the thymus by circulating progenitors at early time points (Porritt et al., 2004).
Bone marrow (CD45.2) cells were intravenously injected into congenic mice (CD45.1).
Thymocytes of recipient mice were prepared 22 to 72 hours later, and donor cells isolated
using a generous gate that included some host cells. Sorted cells were then plated on
OP9-DL4 in the presence of cytokines IL-7 and Flt3-ligand. Between two and three
weeks, cultures were analyzed for Thy1+CD25+ DN3-phenotype T lineage precursors of
donor origin (Figure 2.1A), confirming the presence of T-lineage competent progenitors.
In these homing assays we are measuring the presence or absence of the donor
population; the percentage of donor cells inversely corresponds to the amount of
inclusion of host cells from the sort.
To verify the validity of this assay to measure homing, LMPP deficient in CCR7 and
CCR9 were used as donor cells in a short-term homing assay. CCR7 or CCR9 are
required for progenitor trafficking to the thymus; however, compared to WT progenitors,
CCR7/CCR9 double knockout progenitors are equally efficient at proliferating and
differentiating in response to Notch signals in vivo and in vitro, but are defective in
homing to the thymus (Saran et al., 2010). T lineage cells of donor CCR7/CCR9 double
knockout origin were not detected in the cocultures (Figure 2.1B).
2.2.2 Thymic settling progenitors are found within LMPP and CLP
We next examined the ability of different bone marrow progenitors to home to the
thymus. HSC, MPP, LMPP, and CLP were sorted from CD45.2 mice as lineage-markers
negative (Lin-), and identified using expression of Sca-1, Kit, and IL-7Rα and
intravenously transplanted into congenic CD45.1 recipient mice (Kondo et al., 1997;
Morrison and Weissman, 1994). Only LMPP and CLP were each able to home to the
thymus within 22 hours (Figure 2.2), consistent with the known expression of CCR7,
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CCR9, and functional PSGL-1 on these progenitors, but not upstream HSC and MPP
(Krueger et al., 2010; Sultana et al., 2012; Zlotoff et al., 2010).
2.2.3 Very few cells settle the thymus
To estimate the number of progenitors entering the thymus, we performed a short-term
homing assay in which sorted cells were plated on OP9DL4 at limiting dilution. We
found that approximately 7 and 30 progenitors homed to the thymus from 1x107 and
4x107 bone marrow cells respectively (Figure 2.3). We calculated the fraction and
number of LMPP and CLP within the injected total bone marrow population, and
estimated that approximately 4–5 out of 10,000 LMPP and CLP can be shown to settle
the thymus within 22 hours. Hence very few intravenously injected cells directly home to
the thymus, and this process requires expression of CCR9 and/or CCR7 by progenitors.
2.3 Discussion
We report here that under physiologic conditions, approximately 1 out of 2300
intravenously injected lymphoid progenitors are thymic settling progenitors highlighting
the inefficiency of this process. The reasons for the low frequency of circulating
progenitors that home to the normal thymus are still unclear. Several nonexclusive
possibilities exist, among them: 1) there may be additional homing molecules required,
which would further restrict trafficking to the thymus within these populations; 2) other
tissues trap or attract progenitors of T cells, reducing the supply available to the thymus.
The identity of thymic-homing progenitors has been controversial; and LMPP and/or
CLP have each been proposed to directly settle the thymus (Saran et al., 2010; Serwold et
al., 2009). We demonstrate that both LMPP and CLP, but not earlier progenitors, can
home to the thymus when intravenously injected into normal unconditioned mice. These
demonstrated abilities of LMPP and CLP align with the expression of CCR9 and CCR7
by these progenitor populations (Zlotoff et al., 2011), and also with their expression of
functional PSGL-1 (Sultana et al., 2012).
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In summary, we show that more than one T lineage progenitor is able to seed the thymus.
We confirm that LMPP and CLP are the only BM resident hematopoietic progenitors that
home to the thymus under physiological condition. Identification of two different
progenitors may reflect the existence of multiple T cell development pathways that
dominate in different circumstances. Precise and accurate identification of the T lineage
precursors present in the BM that seed the thymus will provide the answer to a longstanding question in the field of T cell development. This knowledge may have
implications for the development of better therapies for people receiving bone marrow
transplants (HSCT), since for many such patients adequate T cell reconstitution is
problematic.

26

Figure 2.1 Developing an assay to measure homing of progenitors to the thymus. (A)
Schematic for experimental design of short-term homing assay. Bone marrow cells
(CD45.2) were intravenously injected into congenically marked recipients (CD45.1). 22
hours after, thymi were harvested from recipient mice and donor cells were sorted and
plated on OP9-DL4 cultures in the presence of IL-7 and Flt3 ligand. Cocultures were
analyzed two to three weeks later. (B) Short-term homing assay of LMPP sorted from
2x107 BM of WT or CCR7/CCR9 double knockout bone marrow intravenously injected
into WT recipients. (n = 2)
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Figure 2.2 Thymic settling progenitors are present only within LMPP and CLP
subsets. Short-term homing assay of HSC, MPP, LMPP, and CLP sorted from 2x107 WT
BM. Each population was intravenously injected into WT recipients. Cocultures were
analyzed two to three weeks later. (n = 3)
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Figure 2.3 Few bone marrow-derived progenitors settle the thymus. 107 or 4x107
bone marrow cells were intravenously injected into unirradiated mice. 22 hours after,
donor cells were sorted and plated on OP9-DL4 cultures in limiting dilution in the
presence of IL-7 and Flt3 ligand. Correlation coefficients between BM dose and
progenitor numbers were greater than R=0.9. The frequency of progenitors in the sorted
population was calculated using L-calc software based on the number of donor-derived
Thy1+CD25+ positive wells. Nonspecific cell loss was approximated by measuring the
number of Lin-CD25+ DN3 cells before and after depletion. Left: representative FACS
plots gated on sorted donor cells, right: estimated number of thymic settling progenitors.
(n = 3) Representative flow cytometric plots are shown. Data are represented as mean ±
s.e.m. * P<0.05 compared to unirradiated.
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3. CHAPTER III: DELIVERY OF PROGENITORS TO THE THYMUS
LIMITS T LINEAGE RECONSTITUTION AFTER BMT
3.1 Introduction
T-cells provide critical immune protection from a range of pathogens. The T-lineage is
the slowest to recover following irradiation and bone marrow transplantation (BMT), a
delay that impairs immunologic protection of the host (Storek et al., 2008). Peripheral Tcell reconstitution after BMT occurs through two mechanisms: one thymus-independent
and one thymus-dependent. First, radioresistant host T-cells and donor T-cells provided
in the graft homeostatically proliferate in the lymphopenic post-irradiation environment
(Alpdogan et al., 2003; Mackall et al., 1995). Although this population expansion can
partially correct numerical T-cell defects, the resulting cells are functionally
compromised (Beatty et al., 2009; Mackall et al., 1996). The functional recovery of the
T-lineage relies on the second mechanism: the de novo generation of naïve T-cells in the
thymus (Douek et al., 2000; Roux et al., 2000). The generation of thymus-derived naïve
T-cells can take years, and is particularly slow in adults (Hakim et al., 2005; Mackall et
al., 1995; Storek et al., 2008). The reasons for this delay are not fully understood, but
have been suggested to involve impaired intrathymic development due to thymic stromal
damage from conditioning regimens, age-related thymic involution, and graft-versus-host
disease (GVHD) (Chung et al., 2001; Weinberg et al., 2001; Wils et al., 2007).
The thymus does not contain self-renewing progenitors and therefore requires the
importation of circulating bone marrow (BM)-derived progenitors to sustain
thymopoiesis (Goldschneider et al., 1986; Scollay et al., 1986; Shortman and Wu, 1996).
Thymic settling, however, is suggested to be a rare event and the identity of thymic
settling progenitors (TSPs) remains unclear (Ceredig et al., 2007; Spangrude and Scollay,
1990; Wallis et al., 1975). All progenitors descend from hematopoietic stem cells
(HSCs), which are phenotypically negative for lineage markers (Lin) and are additionally
Kit+Sca1+Flt3–. Directly downstream of HSCs are non-renewing multipotent progenitors
(MPPs; Lin–Kit+Sca1+Flt3low) (Adolfsson et al., 2001), which in turn give rise to
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lymphoid-primed multipotent progenitors (LMPPs; Lin–Kit+Sca1+Flt3high) and more
downstream common lymphoid progenitors (CLPs; Lin–KitlowSca1lowFlt3highIL-7Rα+)
(Adolfsson et al., 2005; Kondo et al., 1997). Each of these progenitor types, plus
additional progenitors, has been demonstrated to possess T-lineage potential (Krueger
and von Boehmer, 2007; Scimone et al., 2006). Prethymic hematopoiesis thus provides a
multitude of progenitors with the ability to contribute to T-lymphopoiesis.
The process of thymic settling in normal hosts is selective, as only certain BM
progenitors possess the capacity to enter the thymus from blood (Schwarz et al., 2007).
The chemokine receptors CCR7 and CCR9 underlie part of this selectivity; each receptor
independently supports the importation of progenitors into the thymus (Krueger et al.,
2010; Schwarz et al., 2007; Uehara et al., 2002; Wurbel et al., 2006; Zlotoff et al., 2010).
Thymic settling under competitive conditions is near-absolutely restricted in the absence
of both receptors (Krueger et al., 2010; Zlotoff et al., 2010). The P-selectin ligand PSGL1 also supports thymic settling.(Rossi et al., 2005b) Subsets of LMPPs and CLPs express
functional CCR7 and CCR9, whereas HSCs and MPPs do not (Schwarz et al., 2007;
Zlotoff et al., 2010). Consistently, all thymic settling capacity effectively resides within
the BM Lin–Kit+Flt3high pool, which includes both Kithigh LMPPs and Kitlow CLPs but
excludes HSCs and MPPs (Saran et al., 2010; Schwarz et al., 2007; Serwold et al., 2009).
These Lin–Kit+Flt3high progenitors undergo Notch-dependent differentiation into early
thymic progenitors (ETPs) upon thymic entry (Sambandam et al., 2005; Tan et al., 2005).
ETPs generate CD4/CD8 double-negative 2 (DN2) cells and then DN3 cells. After βselection, DN3 cells become CD4/CD8 double-positive (DP) cells; following positive
selection, DP cells give rise to CD4 and CD8 single-positive (SP) thymocytes, which
emigrate from the thymus to comprise the peripheral naïve T-cell pool.
Our present knowledge of molecules that mediate normal thymic settling derives from
unirradiated hosts, but thymic settling after irradiation is not well understood. Irradiation
is often used as part of a cytoablative conditioning regimen prior to BMT (Adkins and
DiPersio, 2008). After irradiation, radioresistant intrathymic precursors proliferate and
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differentiate to initially reconstitute the thymus (Bosco et al., 2010; Zuniga-Pflucker and
Kruisbeek, 1990). These host thymocytes do not self-renew, and long-term thymopoiesis
after BMT requires thymic settling by donor progenitors. However, the effects of
irradiation on the signals and cells involved in thymic settling are not known.
We investigated the mechanisms of early thymic reconstitution following BMT. We
found that the requirement for CCR7 and CCR9 in thymic settling is relaxed acutely
following irradiation, though PSGL-1 retains a key role. This initial stage of
CCR7/CCR9-independent thymic settling is temporary, and a strict requirement for these
receptors is restored by three weeks after irradiation. BM progenitors that can efficiently
repopulate the thymus are poorly reconstituted for at least four weeks following BMT.
Furthermore, the intrathymic progenitor niche remains unsaturated for at least 10 weeks
after BMT, suggesting that impairments prior to thymic entry limit T-lineage
reconstitution. Indeed, we find that the delivery of more progenitors into the thymus by
direct intrathymic transfer enhances thymic recovery. These data establish that the
mechanisms of thymic settling after irradiation vary from those in normal mice.
Furthermore, they indicate that limited entry of hematopoietic progenitors into the
thymus after BMT impairs T-cell recovery.
3.2 Results
3.2.1 Efficient thymocyte generation by BM Lin–Kit+Flt3high progenitors two weeks
after BMT
Whereas the precise identity of TSPs used in the unirradiated scenario is unknown, these
cells reside within the BM Lin–Kit+Flt3high pool (Saran et al., 2010; Schwarz et al., 2007;
Serwold et al., 2009). To test whether the ability to rapidly produce thymocytes two
weeks after BMT is limited to the BM Lin–Kit+Flt3high pool, we sorted either total Lin–
cells or Lin– cells depleted specifically of the Kit+Flt3high pool (Figure 3.1A). Equal
numbers of these two populations were injected intravenously into mice that had
undergone BMT two weeks earlier. After a further two weeks, BM and thymi of recipient
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mice were analyzed for donor contributions. Both transferred populations contributed to
the BM granulocyte pool, but the Kit+Flt3high-depleted population was defective at
generating thymic DP cells (Figure 3.1B-C). These data indicate that just as in the
unirradiated scenario, efficient thymocyte progenitor activity resides within the BM Lin–
Kit+Flt3high pool two weeks after BMT.
3.2.2 Defective reconstitution of BM Lin-Kit+Flt3high progenitors after BMT
Having established that BM Lin–Kit+Flt3high cells are critical for thymic reconstitution,
we evaluated whether their generation was impaired after BMT. We generated noncompetitive irradiation chimeras in which CD45.1 WT hosts were transplanted with one
of three different doses of CD45.2 BM: 2.5x105, 106, or 4x106. Two weeks after BMT,
we analyzed the BM Lin– pool for the presence of donor Kit+Flt3high cells. While these
cells comprised more than 10% of the Lin– pool in unirradiated control BM, they
represented less than 3% of donor Lin– cells in chimeras receiving each of the three BM
doses (Figure 3.2A-B). Additionally, since total BM cellularity is very low early after
transplantation, these Kit+Flt3high cells had even more severe defects in absolute number
(Figure 3.2B). Impaired reconstitution of these cells continued to be evident four weeks
after irradiation, though the magnitudes of the defects were not as severe as at two weeks
(Figure 3.2B). Furthermore, the frequency and number of Kit+Flt3high cells at this time
point correlated with the BM transplant dose. Resolution of Lin–Kit+Flt3high cells into
LMPPs and CLPs revealed reduced frequencies and numbers of these lymphoid
progenitors (Figure 3.3). Frequencies of MPPs and common myloid progenitors were
also decreased, but the frequencies of granulocyte-macrophage progenitors and
megakaryocyte-erythroid progenitors were not.
We assessed the ability of progenitors from post-BMT mice to generate T-lineage
(CD25+Thy1+) progeny in vitro using co-culture with OP9 stromal cells expressing the
Notch ligand DL4 (OP9-DL4) (Schmitt and Zuniga-Pflucker, 2006). Unfractionated
donor Lin– progenitors sorted from post-BMT mice generated fewer T-lineage progeny
than progenitors from unirradiated mice (Figure 3.4A-B). To identify whether this deficit
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was solely due to the decreased frequency of Kit+Flt3high cells, we sorted Kit+Flt3high cells
and all remaining Lin– cells (i.e. non-Kit+Flt3high) from unirradiated and post-BMT mice
and plated them at their in vivo physiologic ratio. Kit+Flt3high cells from post-BMT mice
were not defective at generating T-lineage progeny relative to their counterparts from
unirradiated mice. The non-Kit+Flt3high cells produced very few T-lineage progeny
(Figure 3.4C). These data indicate that the reduced number of T-lineage cells generated
by unfractionated Lin– progenitors from post-BMT mice is attributable to the reduced
frequency of Kit+Flt3high cells, and not to an intrinsic proliferative defect of these
progenitors. Together these data indicate that the reconstitution of efficient T-lineage
progenitors in the BM is impaired following BMT.
3.2.3 An unsaturated intrathymic progenitor niche persists for at least ten weeks
following BMT
The reduced numbers of BM Lin–Kit+Flt3high progenitors competent to settle the thymus
suggested that the frequency of thymic settling may be reduced after BMT. Indeed, a
previous report noted that the thymus is nearly devoid of ETPs and DN2 cells for at least
four weeks after BMT (Maillard et al., 2006). However, this deficit of Kithigh intrathymic
progenitors does not alone demonstrate that thymic settling is reduced; it is possible that
intrathymic mechanisms impair the generation or survival of these progenitors. To
distinguish between these possibilities, we investigated whether the scarcity of Kithigh
thymic progenitors reflected a vacant intrathymic progenitor niche after BMT. We first
confirmed the near-absence of ETPs and DN2 cells in mice two weeks after BMT and
noted the resemblance of these thymi to those of CCR7/CCR9 DKO mice, a strain which
has highly inefficient thymic settling (Krueger et al., 2010; Zlotoff et al., 2010). Both
have severe defects in the frequencies of ETPs and DN2 cells, but the frequency of DN3
cells is normal (Figure 3.5A). We have previously shown that progenitors placed into
CCR7/CCR9 DKO thymi undergo compensatory proliferation, presumably due to
reduced competition for progenitor niches (Zlotoff et al., 2010). We therefore
hypothesized that if the reduced number of Kithigh thymic progenitors in post-BMT mice
reflects a vacant intrathymic progenitor niche, cells transferred into post-BMT thymi
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should also expand in a compensatory manner. Sorted BM Lin–Kit+Flt3high cells were
intrathymically injected into hosts that had undergone BMT two weeks earlier or into
unirradiated controls. We analyzed host mice two weeks after intrathymic injection, as
this is a time point by which significant numbers of donor DN3 and DP cells have been
generated. At this time, cells transferred into “pre-transplanted” hosts had generated 25fold more donor DN3 cells and 190-fold more donor DP cells (Figure 3.5B-C). Similar
experiments were performed with hosts that had been transplanted four or ten weeks
before intrathymic injection (Figure 3.5C). In both cases, cells placed in pre-transplanted
hosts generated significantly more downstream DN3 and DP progeny than cells injected
into unirradiated hosts. The magnitudes of these differences, however, became
progressively smaller as the time between BMT and intrathymic injection grew longer.
These data demonstrate that progenitors placed into post-BMT thymi undergo
compensatory expansion. We interpret this to signify the presence of unsaturated
intrathymic progenitor niches in post-BMT thymi extending at least ten weeks after
transplantation. Hence, the reinstatement of normal thymic settling signals is decoupled
from the maintenance of a saturated intrathymic progenitor niche following BMT.
3.2.4 Early thymic reconstitution is limited by the number of progenitors delivered to
the thymus
The persistence of an unsaturated progenitor niche suggested that thymic reconstitution
may be limited by the number of progenitors that settle the thymus after BMT (Wils et
al., 2007). To address this, we generated non-competitive irradiation chimeras in which
CD45.1 WT hosts were transplanted with different doses of CD45.2 BM. A previous
study used a similar approach to address this question (Chen et al., 2004). We examined
recipient thymi two weeks after BMT and found that the numbers of donor-derived DN3
and DP cells directly correlated with the BM dose given (Figure 3.6A-B). While total
(donor plus host) DN3 cell number also correlated with BM dose, total DP cell number
did not because at two weeks after irradiation, the majority of DP cells are comprised of
the progeny of radioresistant host thymocytes (Bosco et al. 2010). Mice analyzed four
weeks after BMT also revealed dose-dependent thymic reconstitution (Figure 3.6C-D).
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These data indicate that the magnitude of early thymic reconstitution is limited by the
BM dose provided at the time of transplant.
We next tested whether the enhanced thymic recovery observed after high-dose BMT
was due to an increased number of donor progenitors entering the thymus. Recipient
CD45.1 WT mice were first sublethally irradiated and intravenously inoculated with
2.5x105 CD45.2 WT donor BM cells. Half of these mice were then intrathymically
injected with 3x104 Lin– CD45.2 WT donor BM cells, while the other half were
intrathymically injected with PBS as controls. We analyzed the thymi and spleens of
these mice four weeks after transfer because donor peripheral T-cells can be reliably
quantified at this time point. Mice that had received cells intrathymically possessed
significantly more donor cells among all thymic populations analyzed, which included
DP, CD4 SP, and CD8 SP cells (Figure 3.7A-B); this was true of splenic CD4 and CD8
T-cells as well (Figure 3.7C-D). Similar donor numbers of splenic B cells were found in
both cohorts as expected. These data establish that increased progenitor recruitment to the
thymus after BMT improves T-cell reconstitution. Together these findings illustrate that
T-lineage reconstitution after BMT is limited by the availability of progenitors to the
thymus; thus, not all delays in T-lineage reconstitution are attributable to thymus-intrinsic
mechanisms (Chung et al., 2001; Weinberg et al., 2001).
3.3 Discussion
Thymic settling into unirradiated thymi relies on contributions of CCR7, CCR9, and
PSGL-1. After BMT, PSGL-1-/- progenitors retained a defect in thymic settling at all time
points analyzed, demonstrating a preserved role for this molecule after irradiation. In
contrast, dependence on CCR7/CCR9 can distinguish three distinct stages of thymic
reconstitution. The acute stage extends to four days from BMT, during which most
thymic reconstitution is independent of CCR7 and CCR9. A transitional stage, between
day four and week three post-BMT, relies heavily but not absolutely on CCR7/CCR9 for
thymic reconstitution. During the chronic third stage proceeding from week three
onwards, CCR7/CCR9 are again strictly required. We found that thymic and peripheral
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T-cell reconstitution directly corresponds to the number of cells that enter the thymus
after BMT, indicating that T-lineage reconstitution is limited by the number of available
progenitors. Together these data illustrate that the mechanisms of early T-cell
development after BMT are different from those in unirradiated mice. An important
implication of this observation is that acutely irradiated hosts are not appropriate models
with which to study the mechanisms of normal unirradiated thymic settling. Conversely,
models of physiological thymic settling are a poor approximation for the mechanisms at
play in regeneration after BMT.
Efficient thymocyte generation capacity two weeks after BMT resides in the BM Lin–
Kit+Flt3high pool, which contains cells expressing CCR7 and CCR9. The available supply
of these progenitors in the BM is significantly diminished following BMT. Therefore the
re-imposition of a requirement for CCR7/CCR9 in thymic settling likely reduces the
number of progenitors entering the thymus following BMT – effectively “starving” the
thymus. We consider the chronic vacancy of the intrathymic progenitor niche to
demonstrate that progenitor input into the thymus limits T-lineage reconstitution. Our
observation that the intrathymic progenitor niche remains unsaturated ten weeks after
BMT further suggests the possibility that the niche may never return to a saturated state.
In other words, diminished delivery of progenitors to the thymus may permanently limit
T-cell recovery following BMT.
The reduced delivery of progenitors into the thymus after BMT could have multiple
causes. The prethymic mechanisms in T-cell development can be considered as three
sequential steps (Schwarz et al., 2007). First, the generation of BM progenitors with
thymic settling capacity, then the mobilization of these cells from the BM into the blood,
and finally the entry of these circulating progenitors into the thymus. We evaluated the
first step and found that the rare Lin–Kit+Flt3high BM subset with efficient thymic
repopulating ability is poorly reconstituted, and this impairment persists for at least a
month after BMT. The reasons for the defective regeneration of the BM Lin–Kit+Flt3high
pool remain unclear; they may involve the altered BM cytokine milieu following
37

irradiation (Han et al., 2006). Additional prethymic defects in T-lineage reconstitution
remain possible, such as decreased mobilization or thymic settling of these progenitors.
Thymic reconstitution after BMT was thought to be hampered by three major causes: 1)
thymic stromal damage from conditioning (radiation or chemotherapeutic drugs); 2)
thymic involution in adults; and 3) GVHD targeting the thymus (Chung et al., 2001;
Clave et al., 2009; Krenger and Hollander, 2008; Storek et al., 2002; Wils et al., 2007).
We have investigated the ability of the thymus to generate T-cells after BMT, but certain
caveats exist. We used young mice as hosts, and therefore our results may not be
representative of thymic reconstitution in aged humans with involuted thymi.
Furthermore, we have used a syngeneic transplant model and thus have avoided any
defects that GVHD could have caused. Nevertheless, we found that despite lethal
irradiation, the thymus was quite capable of supporting the extensive expansion of donor
cells provided intravenously or intrathymically. This does not exclude the possibility that
the thymi were impaired relative to unirradiated counterparts. Rather, we interpret this
result to mean that donor thymocyte generation in the irradiated thymus benefits from the
lack of competition more than it suffers from stromal damage.
The three proposed mechanisms of delayed T-lineage reconstitution noted above all
occur at the level of the thymus; we now demonstrate that mechanisms prior to thymic
entry also contribute. Consistent with an earlier study,(Chen et al., 2004) we found that
increasing the number of progenitors delivered to the thymus, either physiologically via
the blood or by direct intrathymic transfer, led to corresponding increases in thymic size
and peripheral donor T-cell numbers. Hence, T-cell reconstitution is limited by what is
likely to be an extremely diminished rate of progenitor entry into the thymus after BMT;
this defect is not mutually exclusive with the intrathymic ones previously noted. The
underrepresentation of Lin-Kit+Flt3high BM progenitors following BMT suggests that
efforts to expand the pool of efficient T-cell progenitors in the BM would be beneficial
towards T-lineage recovery post-BMT. Indeed, a previous report has shown that the
exogenous administration of Flt3 ligand after BMT expanded the MPP and CLP pools
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after BMT and also led to enhanced thymic reconstitution (Wils et al., 2007). The
injected Flt3 ligand may have improved donor thymopoiesis by direct intrathymic effects
(Kenins et al., 2008), but our data suggest that increasing the BM supply of efficient Tlineage progenitors alone may improve thymic recovery. Elucidating new protocols to
improve the reconstitution of such progenitors may be beneficial towards restoring the Tlineage after BMT.
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Figure 3.1 Efficient T-lineage progenitor activity resides within the BM LinKit+Flt3high pool 2 weeks after BMT. (A) Total Lin cells or Lin cells depleted of all
Kit+Flt3high cells were sorted from CD45.2 WT BM. Shown are plots of sorted
populations gated on live singlets. No Kit+Flt3high cells were detected in the depleted
sample. (B) A total of 1.2 x105 undepleted Lin cells (left column) or Kit+Flt3high-depleted
Lin cells (right column) were injected into CD45.1 WT recipients that had been lethally
irradiated and transplanted with 2.5x105 host-type BM cells 2 weeks earlier. After an
additional 15 days, BM and thymi of recipient mice were analyzed for donor
contributions. Shown are representative plots gated on BM granulocytes (top row) and
thymic DP cells (bottom row). (C) Mean donor chimerism plus or minus SEM of BM
granulocytes (left panel) and mean numbers plus or minus SEM of donor thymic DP cells
(right panel). N = 3 to 6 per group.
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Figure 3.2 Defective reconstitution of BM Kit+Flt3high progenitors after BMT. (A)
Noncompetitive chimeras were generated by lethally irradiating CD45.1 WT hosts and
reconstituting them with 2.5 × 105, 1 × 106, or 4 × 106 CD45.2 WT BM cells. Two weeks
after BMT, the BM was analyzed for donor contribution to progenitor populations.
Shown are representative plots from chimeras transplanted with the indicated cell
number; plots are gated on donor Lin− cells (or total Lin− cells for the unirradiated
control). (B) Shown are the mean frequencies ± SEM of Kit+Flt3high cells among donor
Lin− cells for unirradiated controls and each of the 3 chimera cohorts 2 weeks after BMT
(top left panel). Multiplying these frequencies by the total leg (tibia plus femur) BM
cellularity yielded the mean numbers ± SEM of donor Lin−Kit+Flt3high cells (top right
panel). The same frequency (bottom left panel) and absolute number (bottom right panel)
measurements were made on similar chimeras 4 weeks after BMT. **P < .01 compared
with the corresponding unirradiated controls. N = 3 per group.
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Figure 3.3 Defective generation of BM progenitors after BMT.
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Fig

Non-competitive chimeras were generated by lethally irradiating CD45.1 WT hosts and
reconstituting them with 106 CD45.2 WT BM cells. Four weeks later, the mice were
sacrificed and the BM was analyzed for donor contribution to the following progenitors:
long-term HSCs (LT-HSC; Lin–Kit+Sca1+Flt3-CD150+CD34–), short-term HSCs (STHSC; Lin–Kit+Sca1+Flt3-CD150+CD34+), common myeloid progenitors (CMP; Lin–
Kit+Sca1–CD34+CD16/32mid), granulocyte-macrophage progenitors (GMP; Lin–Kit+Sca1–
CD34+CD16/32high), and megakaryocyte-erythroid progenitors (MEP; Lin–Kit+Sca1–
CD34–CD16/32low). (A) Shown are the mean frequencies ± SEM for the indicated
progenitor population among donor Lin– cells (or total Lin– cells for unirradiated
controls). (B) Multiplying these frequencies by the total leg (tibia plus femur) BM
cellularity yielded the mean number ±SEM of each progenitor population. * p < 0.05; **
p < 0.01. N = 3 per group.
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Figure 3.4 Defective generation of T lineage cells by donor progenitors after BMT.
(A) To test the ability of donor BM progenitors to generate T lineage cells, CD45.2+Lin–
cells were sorted from unirradiated CD45.2 control mice and from CD45.1 mice
transplanted four weeks earlier with 2.5x105, 106, or 4x106 CD45.2 BM cells. 1000
cells were plated on OP9-DL4 stromal layers and incubated for 10 days, after which
recovered cells were analyzed for expression of CD45.2 and the T lineage markers CD25
and Thy1. Shown are representative plots of GFP–CD45.2+ cells (OP9-DL4 cells are
GFP+CD45.2–) from each group. (B) Shown are the mean relative numbers ± SEM of T
lineage cells (CD25+Thy1+) recovered from triplicate wells of each type described in (A).
* p<0.05 for the comparison to the unirradiated control. (C) Lin–Kit+Flt3high cells and
Lin– non-Kit+Flt3high cells were sorted from unirradiated CD45.2 mice and from
CD45.1 mice transplanted two weeks earlier with 2x106 CD45.2 BM cells. The numbers
of cells plated per well reflected the in vivo ratio between these two pools found in
unirradiated mice, which is approximately 1:5.3. Therefore, 300 Lin–Kit+Flt3high cells or
1600 Lin– non- Kit+Flt3high cells were plated on OP9-DL4 stromal layers. After 10 days
of culture, cells were collected and analyzed as in (A). Shown are the mean relative
numbers ± SEM of T lineage cells recovered from quadruplicate wells of each type.
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Figure 3.5 Chronic vacancy of intrathymic progenitor niches after BMT. (A) Thymi
from unirradiated, CCR7/CCR9 DKO, or 2 weeks post-BMT mice were analyzed for the
frequency of Kithigh thymic progenitors. Shown are representative plots gated on Lin−
thymocytes. (B) Sorted CD45.2 donor BM Lin−Kit+Flt3high progenitors were injected
intrathymically into either unirradiated CD45.1 hosts (left column) or CD45.1 hosts that
had been lethally irradiated and transplanted with 2.5 × 105 CD45.1 BM cells 2 weeks
earlier (right column). Recipient thymi were analyzed for donor contributions 2 weeks
later. Shown are representative plots of thymic DN3 cells (top row) or DP cells (bottom
row). (C) The mean numbers ± SEM of donor DN3 cells (left) and DP cells (right) in the
recipient thymi described in panel B are shown (top row). The same experiment was also
performed with recipients that had undergone BMT 4 weeks (middle row) or 10 weeks
(bottom row) before intrathymic injection. *P < .05, compared with the corresponding
unirradiated control. **P < .01 compared with the corresponding unirradiated control. N
= 3 to 10 per group.
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Figure 3.6 Early thymic reconstitution correlates with BM graft size. (A) CD45.1
WT mice were lethally irradiated and transplanted with the indicated number of CD45.2
WT BM cells. Shown are representative plots of the indicated thymic populations two
weeks after BMT. (B) Mean numbers ± SEM of host and donor DN3 (left panel) and DP
(right panel) cells in the chimeras described in (A). p value for comparisons between
donor DN3 cell numbers in recipients of 2.5x105
and of 106: p = 0.011; between
5
6
recipients of 2.5x10 and of 4x10 : p = 0.0002; between recipients of 106 and of 4x106:
0.049. p values for all comparisons of donor DP cells were greater than 0.05. N = 3 per
group. (C) Chimeras identical to those in (A) were analyzed at four weeks. Shown are
representative plots of the indicated thymic populations from mice in each group. (D)
Shown are the mean numbers ± SEM of host and donor DP (top panel), CD4 SP (bottom
left panel), and CD8 SP (bottom right panel) cells in the chimeras described in (C). p
values for comparisons of donor DP, CD4 SP, and CD8 SP cell numbers between
recipients of 2.5x105 cells and of 4x106 cells were all below 0.01. No comparisons of
donor cell numbers between the recipients of 2.5x105 cells and of 106 cells or between
recipients of 106 cells and of 4x106 cells yielded p values less than 0.05. N = 3 per group.
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Figure 3.7 Limiting numbers of thymic progenitors delay T-lineage recovery. (A)
CD45.1 WT host mice were sublethally irradiated and intravenously injected with
2.5×105 CD45.2 WT BM cells. Immediately thereafter, one group of mice received PBS
intrathymically (IV only), whereas another group received 3×104 CD45.2 Lin− BM cells
intrathymically (IV + IT). Host thymi and spleens were analyzed for donor contributions
4 weeks later. Shown are representative plots of thymic DP (top row), CD4 SP (middle
row), and CD8 SP (bottom row) cells from mice in the indicated groups. (B) Mean
numbers ± SEM of host and donor thymic DP (top panel), CD4 SP (bottom left panel),
and CD8 SP (bottom right panel) cells from the chimeras described in panel A. P values
for comparisons of donor DP cell numbers between the 2 groups, .01; of donor CD4 SP
cell numbers, .002; of donor CD8 SP cell numbers, .0003. (C) Shown are representative
plots of splenic CD4 T (top row), CD8 T (middle row), and B (bottom row) cells from
mice in the indicated groups described in panel A. (D) Graphs show the mean number ±
SEM of host and donor splenic CD4 T (top left panel), CD8 T (top right panel), and B
(bottom panel) cells from the chimeras described in panel A. P values for comparisons of
donor CD4 cell numbers between the 2 groups, .007; of donor CD8 cell numbers, .005; of
donor B cell numbers, .41. N = 4 or 5 per group.
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4. CHAPTER IV: CHEMOKINE PRETREATMENT RESCUES
PROFOUND T LINEAGE PROGENITOR HOMING DEFECT
AFTER BMT CONDITIONING
4.1 Introduction
T cells are an important component of the adaptive immune system in combating
infection. Following bone marrow transplant (BMT), T cells are among the last of the
hematopoetic lineages to recover, leaving patients susceptible to infection for a prolonged
period (Bosch et al.; van Den Brink et al., 2013). After BMT, peripheral T cells recover
through two mechanisms 1) thymus-independent homeostatic expansion of radioresistant
cells and 2) thymus-dependent maturation of progenitor cells (Douek et al., 2000;
Mackall et al., 1996). Although both mechanisms increase T cell numbers, the latter
mechanism restores diversity of T cell receptors and a functional peripheral T cell
population (Roux et al., 1996). However, the regeneration of T cells from the thymus is
slow and can take years, which is further impeded by graft-versus-host disease (GvHD)
and age-related thymic involution in humans (Castermans et al., 2011; Krenger et al.,
2011; Weinberg et al., 2001). The reasons for the prolonged delay in thymus-derived T
cell reconstitution are unclear.
Under physiologic conditions, the thymus does not contain self-renewing progenitors,
thus requiring importation of progenitors from the blood that originate in the bone
marrow (Donskoy and Goldschneider, 1992). Although many bone marrow stem and
progenitor cells have T lineage potential, and differentiate into T cells when signaled
through Notch, not all such progenitors migrate to the thymus (Krueger and von
Boehmer, 2007; Schwarz and Bhandoola, 2004). In mice, either chemokine receptors 7
(CCR7) or 9 (CCR9) support the trafficking of progenitors into the thymus (Krueger et
al., 2010; Zlotoff et al., 2010). Progenitor homing via CCR9 has also been shown to be
important in fish (medaka) and humans (Bajoghli et al., 2009; Haddad et al., 2006). The
importance of CCR7 in physiologic thymic homing is less clear; however, in the absence
of CCR9, cells can home using CCR7 (Calderon and Boehm, 2011; Vander Lugt et al.,
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2013; Zlotoff et al., 2010). Additionally, functional P-selectin glycoprotein ligand
(PSGL-1) and integrins VCAM-1 and ICAM-1 have been shown to be required for
efficient thymic homing (Rossi et al., 2005b; Scimone et al., 2006; Sultana et al., 2012).
Our understanding of molecules that mediate trafficking of progenitors to the normal
thymus derives from unirradiated hosts; the effect of BMT conditioning on progenitor
trafficking is not well understood.
BMT is preceded by conditioning regimens that most often include alkylating drugs
and/or irradiation (Copelan and Deeg, 1992; Hill-Kayser et al., 2010). In mice, when
thymocytes are exposed to conditioning regimens, many of the hematopoietic cells in the
thymus apoptose and the debris is cleared by neutrophils and macrophages, resulting in
reduced cellularity and decreased size (Kim et al., 2010). Although some T-lineage
precursors can survive the irradiation and proliferate to become peripheral T cells in
rodents, these cells are unable to maintain long-term T cell output (Bosco et al., 2010).
After BMT, colonization of the bone marrow by self-renewing HSC eventually generates
lymphoid progenitors that support thymic recovery; however, in mice, intrathymic niches
remain unsaturated for a prolonged period after radiation and BMT, suggesting that the
migration of progenitors to the thymus after BMT is a rate-limiting step in T cell
recovery (Zlotoff et al., 2010). We examine whether irradiation reduces input of
progenitors, which may contribute to delayed thymic-dependent T-lineage reconstitution
after BMT.
In this study, we use a mouse model to examine homing of bone marrow progenitors after
BMT conditioning. We find that the number of progenitors that settle the irradiated
thymus is reduced to below detectable levels. Radiosensitivity of thymic epithelial cells
(TEC) reduces the total level of chemokine in the thymus and chemokines are reduced on
thymic endothelium. Ex vivo pretreatment of bone marrow progenitors with chemokines
prior to transplantation alters progenitors and increases homing from the circulation to the
irradiated thymus. Together these data suggest that irradiation limits chemokine signals,
slowing thymus-dependent T-lineage reconstitution after BMT. These data suggest a new
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strategy to boost T lineage recovery after BMT in humans.
4.2 Results
4.2.1. Brief CCR7/CCR9-independent thymic settling after BMT
In unirradiated mice, progenitors lacking CCR9 and CCR7 are almost completely unable
to settle the thymus (Krueger et al., 2010; Schwarz et al., 2007; Zlotoff et al., 2010). We
investigated whether thymic settling relies on these same chemokine receptors following
irradiation. We generated two cohorts of lethally irradiated mixed BM chimeras: a
control group mixing wild-type (WT) CD45.2 BM and WT CD45.1 BM, and a second
group mixing CCR7/CCR9 double knock-out (DKO) CD45.2 BM and WT CD45.1 BM.
This method of generating chimeras does not allow us to distinguish donor-derived
“competitor” CD45.1 thymocytes from radioresistant host-derived CD45.1 thymocytes,
but we could evaluate the relative competitiveness of the two “test” CD45.2 cohorts.
Three weeks after irradiation, CCR7/CCR9 DKO chimerism among DP cells was similar
to WT chimerism (Figure 4.1A-B). Yet ten weeks after irradiation, only a trace
contribution to the DP pool from CCR7/CCR9 DKO cells was detected. The absence of
CCR7/CCR9 DKO DP cells at this time is not due to an intrathymic developmental
defect; we previously showed that intrathymically transferred CCR7/CCR9 DKO
progenitors have no defect in generating downstream progeny (Zlotoff et al., 2010). We
also examined these chimeras at two and four weeks after BMT. Donor CCR7/CCR9
DKO chimerism and donor WT chimerism within the DP pool did not become
significantly different until the four week time-point (Figure 1B). CD45.2 chimerism of
the BM granulocyte (SSChighGr-1+) pool was equivalent between the two cohorts across
all time points, ensuring similar BM engraftment. Together these data indicate that
thymic settling can occur independently of CCR7 and CCR9 acutely after irradiation.
The detection of CCR7/CCR9 DKO thymocytes at early times, but not ten weeks, after
BMT implies that the CCR7/CCR9-independent thymic settling induced by irradiation is
temporary. To determine the length of this CCR7/CCR9-independent period, we
generated irradiation chimeras into which the CCR7/CCR9 DKO BM was injected at
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various time points after irradiation (Figure 4.1C). For these experiments, CD45.1 WT
hosts were lethally irradiated and initially transplanted with CD45.1 WT BM to ensure
survival. After waiting various lengths of time, 107 CCR7/CCR9 DKO or WT BM cells
(both CD45.2) plus 2x106 CD45.1 WT BM cells (to provide competition) were
transferred intravenously. Three weeks after transfer, the recipients were analyzed for
CD45.2 donor chimerism. BM granulocytes were examined as a control for successful
BM engraftment by donor cells (Figure 4.1D). CCR7/CCR9 DKO chimerism and WT
donor chimerism were comparable at all time points except in mice receiving donor cells
three weeks after BMT, in which CCR7/CCR9 DKO chimerism was modestly reduced.
Similar levels of CD45.2 donor chimerism among thymic DP cells were observed
between the groups receiving cells on the day of irradiation (Figure 4.1E). In mice
receiving donor cells one to four days following irradiation, substantial CCR7/CCR9
DKO chimerism continued to be observed, though reduced compared to the WT control.
Among mice receiving CCR7/CCR9 DKO BM cells one week after BMT, only three of
six recipients had donor chimerism greater than 1%; at the two week time point, this
fraction fell to one of six. Only trace donor chimerism was detected in all mice receiving
CCR7/CCR9 DKO cells three weeks after BMT. These data suggest that a role for CCR7
and CCR9 in thymic settling is evident within the first four days, but a strict requirement
for these molecules is not reinstated until between two and three weeks after irradiation.
Notably, the absence of CCR7/CCR9 DKO donor chimerism in some recipients in the
one and two week groups suggests that there is variability in the duration of
CCR7/CCR9-independent thymic settling, and a strict requirement for these receptors can
occur within one week of irradiation.
It is possible that after irradiation, physical damage to the thymic vasculature allows for
unregulated entry of circulating T-cell progenitors. Indeed, high dose irradiation can
damage lung and skin endothelium (Friedman, 1986; Hopewell, 1986). We next
examined whether irradiation affects thymic vascular permeability by intravenously
injecting albumin-binding Evans blue one day after irradiation. Increased vascular
permeability to Evans blue was observed in both thymus and lung following a 9.5 Gy
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dose of irradiation, but not a low dose of 1.5 Gy (Figure 4.2A). 1.5 Gy is a sufficient
dose, however, to confer CCR7/CCR9-independence on thymic settling (Figure 4.2B),
indicating that permeability to Evans blue can be uncoupled from CCR7/CCR9independent thymic settling. We further asked whether erythrocytes could enter an
irradiated thymus, which would be expected if endothelial barrier function had been lost.
Following irradiation with 9.5 Gy, there was no detectable increase in the number of
erythrocytes in the thymus (data not shown). Together these data indicate that
CCR7/CCR9-independent thymic settling after irradiation is not due to loss of thymic
endothelial barrier function.
To evaluate whether thymic entry remains regulated after irradiation, we investigated
whether another signal important for normal thymic settling, namely PSGL-1 (Rossi et
al., 2005b), remains relevant. We sought to confirm a role for PSGL-1 in the unirradiated
scenario through the adoptive transfer of unfractionated PSGL-1-/- BM or WT BM (both
CD45.2) into unirradiated CD45.1 WT hosts. Three weeks after transfer, the donor
chimerism of BM granulocytes was similar in the two cohorts, indicating equivalent
engraftment of the BM (Figure 4.2C). The donor chimerism of DN3 cells in recipients of
PSGL-1-/- BM was reduced compared to recipients of WT BM, consistent with a role for
PSGL-1 in unirradiated thymic settling. The role of PSGL-1 in thymic settling after BMT
was tested through the generation of mixed BM chimeras using mixtures of PSGL-1-/BM or WT BM (both CD45.2) and competitor CD45.1 WT BM. Three weeks after BMT,
PSGL-1-/- donor chimerism was equal to WT donor chimerism in the BM granulocyte
pool, but significantly reduced among thymic DN3 cells (Figure 4.2D). These data
demonstrate that a role for PSGL-1-/- in generating thymocytes is maintained after
irradiation. To distinguish between a thymic settling defect and an intrathymic
developmental defect in the absence of PSGL-1, sorted PSGL-1-/- or WT LMPPs were
intrathymically injected into sublethally irradiated WT hosts, bypassing the thymic
settling step. Consistent with past work (Rossi et al., 2005b), PSGL-1-/- progenitors were
not defective at generating downstream DN3 cells, thereby indicating that early
intrathymic development is not reliant on PSGL-1 (Figure 4.3). Together these data
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demonstrate that unlike CCR7 and CCR9, PSGL-1 maintains its role in thymic settling
acutely following BMT.
Collectively, these results indicate that thymic reconstitution after BMT can be divided
into three stages: an acute stage until day four post-BMT during which most thymic
reconstitution is CCR7/CCR9-independent; a transitional stage between day four and
three weeks during which most reconstitution depends on CCR7/CCR9 although these
receptors are not strictly required; and a chronic stage beginning at three weeks requiring
CCR7/CCR9 in all cases.
4.2.2 Irradiation profoundly reduces homing to the thymus
Previously, the thymus was thought to be hyper-receptive to progenitors due to increased
donor engraftment in the thymus found in the weeks following irradiation; however, the
increase in donor engraftment may be due to increased proliferation within the thymus of
rare thymic homing cells rather than a reflection of increased colonization (Foss et al.,
2002). We therefore examined the impact of irradiation on homing. Bone marrow was
injected into congenic recipient mice that were untreated or irradiated with 600
(sublethal) or 900 cGy (lethal). Surprisingly, when host thymi were examined 22, 44, or
72 hours later (for both 600 and 900 cGy), T lineage precursors of donor origin were not
detected in irradiated mice. Compared to controls, irradiated mice had at least a ten-fold
decrease in progenitors that settle the thymus 72 hours after 900 cGy of irradiation
(Figure 4.4A). The homing defect was equally evident when mice were given lower sublethal doses of 600 cGy (data not shown, also see Figure 4.10A). When homing was
bypassed by intrathymic injection of bone marrow or sorted Lin-Kit+Flt3+ progenitors, we
found that progenitors survived the environment of the irradiated thymus (Figure 4.4B),
and intrathymically injected donor bone marrow cells containing T progenitor cells sorted
from either unirradiated and irradiated recipients differentiated into T cell precursors on
OP9-DL4 stromal cells with equivalent efficiency (Figure 4.4C). Together these data
imply that thymic settling was harmed by irradiation rather than the survival or
subsequent proliferation of settled cells.
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It was conceivable that non-thymic tissue damage caused by irradiation also may have
remotely affected homing of progenitors to the thymus (Trott et al., 2012). Using a lead
block to shield either the upper half or lower half of the recipients, we found that 900 cGy
of irradiation of the upper half of the mouse blocked homing of progenitors whereas
irradiation of the lower half did not (Figure 4.5A), indicating that irradiation of nonthymic tissues was not sufficient to impair thymic settling. To ensure that the homing
defect resulted from thymic irradiation, we used computed tomography (CT) scans to
guide a collimator and direct a beam of irradiation 1.1 cm in diameter at the recipient
thymus. Progenitor homing to the thymus was again blocked following targeted
irradiation of the thymus (Figure 4.5B). The near-complete lack of thymic homing was
not permanent, because some homing of progenitors to the irradiated thymus was evident
after two weeks (Figure 4.5C). These results suggest that irradiation of thymus tissue
directly impairs homing to the thymus.
4.2.3 Expression of determinants of homing on endothelial cells
Since both sublethal (600 cGy) and lethal (900 cGy) doses of irradiation ablated thymic
homing, we chose to further examine the thymus of mice given sublethal doses, thus
eliminating the need to prevent the death of the mice with BMT. The thymus is smaller
after irradiation, with greatly reduced numbers of hematopoietic cells; however, we found
that thymic endothelial cell numbers were unaffected after 600 cGy of irradiation (Figure
4.5A), consistent with reports of maintained endothelial numbers at other sites following
irradiation (Li et al., 2008; Schuller et al., 2007). We examined the thymic vasculature by
immunofluorescence microscopy and found that thymic vascular elements appeared
grossly intact one day after irradiation (Supplemental Figure 4.5B). To determine the
mechanism of the homing defect after BMT, we examined endothelial cells for molecules
involved in progenitor cell homing. In addition to chemokine receptors, PSGL-1, LFA-1
(αLβ2) and VLA-4 (α4β1) on bone marrow progenitors are each required for efficient
homing to the thymus (Rossi et al., 2005b; Scimone et al., 2006). We examined the
respective binding partners on endothelial cells – P-selectin, ICAM-1, and VCAM-1
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(Figure 4.5C – E). After 600 cGy irradiation, we found a modest increase in the number
of P-selectin positive endothelial cells, consistent with a previous report (Gossens et al.,
2009), as well as increased levels of ICAM-1 expression and maintenance of VCAM-1
expression. The results suggest that the homing defect is not likely due to defects intrinsic
to endothelial cells.
4.2.4 Chemokines on thymic endothelial cells are reduced by irradiation
We then examined the thymus after sub-lethal doses of irradiation (600 cGy) in search of
a mechanism for reduced homing after irradiation. We found that TECs, like
hematopoietic cells, are radiosensitive (Figure 4.6A; Chung et al., 2001; Williams et al.,
2009). To reduce irradiation-induced TEC apoptosis, we transplanted WT bone marrow
into irradiated p53-deficient recipients. We found that progenitors homed to irradiated
thymus in which TEC numbers were maintained (Figure 4.6B), suggesting that TEC
apoptosis may contribute to the defect in homing.
Robust physiologic homing of T cell progenitors to the thymus relies on CCR9 and
CCR7. Their ligands, CCL25 and CCL21/CCL19 respectively, are expressed by TECs
(Misslitz et al., 2004; Ueno et al., 2004; Wurbel et al., 2000). We isolated TECs (CD45EpCam+), endothelial cells (CD45-CD31+), and hematopoietic cells (CD45+) from
dissociated thymi for qPCR analysis. We found that CCL19, CCL21, and CCL25 mRNA
are primarily synthesized by TECs; but these mRNAs were very low or not detected in
endothelial or hematopoietic cells (Figure 4.7). After 600 cGy irradiation conditioning,
surviving TECs continued to express chemokine mRNAs (Figure 4.7). These results
suggested that even though the few TECs that survive irradiation were still expressing
chemokines, the greatly reduced numbers of TECs might result in decreased total
chemokine available in the thymus.
Chemokines produced by TECs support the homing of circulating cells into tissues via
transcytosis through endothelial cells (Middleton et al., 2002). To examine chemokines
expressed on endothelial cells, we co-stained frozen thymus sections with anti-CD31
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(red) and anti-CCL25 (green). Colocalization of CD31 and CCL25 was evident in an
unirradiated thymus whereas CCL25 was absent on the blood vessels of irradiated 24
hours after irradiation (Figure 4.8-4.9). Two weeks after irradiation, CCL25 was
observed on the blood vessels, coinciding with the restoration of efficient homing (Figure
4.8-4.9). Together these data suggest that the production of chemokines by the few TECs
surviving irradiation may be insufficient to sustain efficient homing in the acute period
after irradiation.
4.2.5 Restoration of chemokine signals rescues thymic homing defect
If inadequate chemokines levels underlie the homing impairment after thymic irradiation,
we predicted that supplying such chemokines to progenitors ex vivo would restore the
defect. To restore chemokine signals to the trafficking progenitors, we pretreated bone
marrow cells with CCL21 and CCL25 at 37°C for 30 minutes. Untreated or pretreated
bone marrow was injected into irradiated recipients. We detected homing of pretreated
bone marrow within 44 hours to irradiated thymi in 5 out of 6 mice (Figure 4.10A). We
have detected CCL21/CCL25-mediated homing to the irradiated thymus as early as 4
hours after injection of donor cells (data not shown). To determine whether chemokine
stimulation was increasing the proliferation or survival of progenitors, freshly isolated
bone marrow progenitors were incubated with CCL21 and CCL25 and cultured on OP9DL4 stromal cells. After 10 days of culture, untreated and treated progenitors gave rise to
similar numbers of Thy1+CD25+ cells (Figure 4.10B). Together, these results support the
interpretation that pretreatment of progenitors with appropriate chemokine ligands did not
affect their survival or proliferation but instead allowed their migration into the thymus.
To determine whether an increase in early homing by chemokine-treated bone marrow
enhances thymic reconstitution, untreated or pretreated bone marrow was injected into
irradiated recipients and the thymus and bone marrow was examined after 14 or 16 days.
At 14 days, donor engraftment in the thymus was increased in recipients that received
pretreated bone marrow, suggesting that signals provided by CCL21 and CCL25
improves thymic reconstitution through increased homing of progenitors (Figure 4.10C).
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To determine whether chemokine treatment of progenitors could be bypassing other
requirements for homing, we incubated bone marrow cells with a blocking antibody
against α4 integrin prior to chemokine pretreatment. α4 integrin blockade prevented the
increase in donor engraftment. Removal of chemokines from lymphocytes returns
integrins to their pre-activation conformation (Constantin et al., 2000). We therefore
assessed thymic reconstitution of pretreated cells that were removed from chemokines for
30 minutes prior to intravenous injection. This also inhibited the CCL21/CCL25mediated increase in donor engraftment (Figure 4.10C). At 14 days after irradiation, the
thymus is largely comprised of host-derived cells that survived the irradiation and
proliferated; however, 16 days after irradiation, the thymus becomes almost equivalently
donor and host. At this time, both donor-derived thymocyte numbers and total thymic
cellularity were significantly increased by pretreatment with CCL21 and CCL25 (Figure
4.10D). Interestingly, improved donor settling in the thymus increased numbers of host
thymocyte populations (data not shown), similar to previous observations (Awong et al.,
2013; Zakrzewski et al., 2006). The facilitated reconstitution of host-derived cells may be
through the restoration of thymic architecture due to lymphocyte–stromal interactions.50
As expected, LSK engraftment in the bone marrow was equivalent between untreated and
pretreated cells (Figure 4.10D), consistent with the absence of CCR7 and CCR9 on HSCs
and MPPs. Another chemokine receptor, CXCR4, although insufficient for efficient
thymic homing physiologically, is broadly expressed on hematopoietic progenitor
populations (Zlotoff et al., 2010). To determine whether signaling via any chemokine
receptor expressed by progenitors is sufficient to restore the defect after irradiation, we
pretreated bone marrow with the CXCR4 ligand CXCL12. Pretreatment with CXCL12
improved thymic reconstitution similar to what was seen with CCL25 and CCL21, but
did not impact bone marrow reconstitution by LSK cells (Figure 4.11). This suggests that
chemokine-induced activation of progenitors does not necessarily require the
physiologically relevant chemokines. CXCR4, CCR7, and CCR9 are all coupled to
Galphai and this shared mechanism would suggest that the consequences for the
progenitors would therefore be qualitatively similar whether signals were provided via
CXCR4, CCR9 or CCR7. Together, these data demonstrate that pretreatment of bone
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marrow progenitors with chemokine signals improves thymic reconstitution, presumably
by increasing the efficiency of thymic settling.
4.3 Discussion
Thymic settling by circulating progenitors likely uses mechanisms analogous to those
used by mature lymphocytes to enter lymph nodes, wherein chemokine signals induce the
conformational change of integrins to a high-affinity state (Scimone et al., 2006). The
irrelevance of CCR7 and CCR9 towards thymic settling acutely after BMT presents two
alternative mechanisms of progenitor entry into the thymus. First, cells may access the
irradiated thymus independently of any chemokine receptor signals. Recent work has
demonstrated that irradiation can damage BM sinusoids, making them discontinuous and
consequently hemorrhagic (Hooper et al., 2009; Li et al., 2008). However, the lack of
thymic vascular permeability to Evans blue after 1.5 Gy (a dose sufficient to confer
CCR7/CCR9-independent thymic settling) (4.2A-B) and the continued reliance on PSGL1 acutely following BMT (Figure 4.2D) together indicate that a loss of endothelial barrier
function does not underlie CCR7/CCR9-independent thymic settling.
During the same period of CCR7/CCR9-independent settling following BMT, we found
that progenitor cell homing becomes undetectable after BMT conditioning, that homing is
limited by chemokine signals, and that exogenous treatment with chemokines restores
thymic homing. Thymic settling by progenitors has been difficult to study, likely because
this event is exceedingly rare (Wallis et al., 1975). The reasons for the low frequency of
circulating progenitors that home to the normal thymus are still unclear. Several
nonexclusive possibilities exist, among them: 1) there may be additional homing
molecules required, which would further restrict trafficking to the thymus within these
populations; 2) other tissues trap or attract progenitors of T cells, reducing the supply
available to the thymus.
Together, these data suggest 2 modes of homing for thymic settling progenitors: 1) the
major contribution is from CCR7/CCR9-dependent homing, used by progenitors
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physiologically, which is profoundly reduced after irradiation; 2) a less efficient
CCR7/CCR9-independent mechanism which is maintained after irradiation. Activation of
progenitor cells by exogenous chemokine treatment increases homing, and subsequently
improves thymic reconstitution, through restoring CCR7/CCR9-dependent homing.
The progenitors trafficking from the blood to the thymus are thought to use selectinmediated rolling, followed by chemokine signals activating integrins on the surface of
trafficking cells. The activation mediates firm binding with adhesion molecules on
endothelial cells, leading to arrest of the rolling cell. The cells are then able to
transmigrate from the vasculature into the organs (Scimone et al., 2006; Springer, 1994).
Endothelial cell numbers and endothelial cell expression of selectins and integrins was
unaffected; however, irradiation resulted in the death of chemokine-producing TECs,
likely reducing chemokine availability to progenitors circulating through the thymic
vasculature.
Providing exogenous chemokine ligands prior to intravenous injection restored thymic
settling of progenitors into irradiated thymi, confirming that chemokine signals are
limiting after irradiation. These data also indicate that a localized chemokine signal or
gradient is not strictly necessary for homing to the thymus. Homing was not rescued in all
of the recipients, which may be due to either additional damage caused by irradiation,
which we have not explored here, or may indicate that the activation of the cells ex vivo
is less efficient than physiologic activation. CCL21 and CCL25 signaling through their
respective receptors have been shown to convert integrins to their high affinity
conformations, which mediate firm adhesion of lymphocytes to the endothelium
(Constantin et al., 2000; Parmo-Cabanas et al., 2007). The integrins VCAM-1 and LFA-1
on lymphocytes are activated by chemokines; however, chemokine stimulation of LFA-1
is transient; the cell adhesion to ICAM-1 lasting on the order of minutes (Constantin et
al., 2000). These data suggest that any chemokine-induced ICAM-1/LFA-1-dependent
progenitor adhesion to the thymic endothelium likely occurs within a few minutes of
intravenous injection. The active conformation of VLA-4 may be slower to revert and
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may used by intravenously injected progenitors to bind to VCAM-1 on thymic
endothelial cells.
Our investigations of thymic reconstitution were performed in a syngeneic transplant
model with young mice, which presents several caveats. Our results may not be fully
representative of thymic reconstitution in aged humans who have involuted thymi. Our
model also avoided any complications that GvHD may have caused. In young mice, we
demonstrate that a small number of LMPP and CLP traffic to the thymus and this amount
of homing is further limited by chemokine signals following irradiation. In young healthy
mice, homing recovered at least partially after two weeks, but whether similar recovery
occurs in all humans awaits further studies. However, our results suggest two possible
methods for enhancing T cell precursor trafficking to the thymus. One method is to
administer a second inoculum containing progenitors (LMPP and/or CLP) after a period
when CCR7/CCR9-dependent efficient thymic homing is re-established in humans. The
second method is pretreatment of bone marrow progenitors with chemokines prior to
transfer into patients. Both may improve T lineage reconstitution following BMT. These
approaches could serve as useful adjuncts to administration of keratinocyte growth factor,
previously shown to increase TEC numbers; and cytokines such as Flt3-ligand, which
targets hematopoietic cells (Kenins et al., 2008; Min et al., 2002). Improving trafficking
of progenitors to the thymus alongside therapies to ameliorate GvHD and thymic
involution may together enhance T cell regeneration following BMT.
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Figure 4.1 A brief stage of CCR7/CCR9-independent thymic settling after BMT.
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(A) Lethally irradiated mixed BM chimeras were generated using CD45.2 WT (left
column) or CD45.2 CCR7/CCR9 DKO (right column) plus CD45.1 WT competitor cells
at a 2:1 ratio (106 total cells). Shown are representative fluorescence-activated cell sorter
plots of thymic DP cells at the indicated time points. (B) Mean CD45.2 chimerism ±
SEM of BM granulocytes (top row) and thymic DP cells (bottom row) for control WT
chimeras (left column) or CCR7/CCR9 DKO chimeras (right column) at the indicated
time points after transplant. *P < .05. **P < .01. N = 2 to 14 per group per time point. (C)
Experimental design for evaluating the duration of CCR7/CCR9-independent thymic
settling after BMT. CD45.1 WT hosts were lethally irradiated and immediately
inoculated with CD45.1 BM (2.5 × 105 cells) to ensure survival. After various lengths of
time, mice were inoculated with CD45.2 donor BM (either WT or CCR7/CCR9 DKO)
and CD45.1 BM at a 5:1 ratio (1.2 × 107 total cells). After 3 additional weeks, BM and
thymi were analyzed for donor chimerism. (D-E) Shown is CD45.2 donor chimerism
among BM granulocytes(D) or thymic DP cells (E) in mice receiving CD45.2 BM cells at
the indicated time points.
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Figure 4.2 Thymic settling remains a regulated process after BMT.
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(A) Evans blue was measured in thymi or lungs after no treatment, lipopolysaccharide
treatment, 1.5 Gy irradiation, or 9.5 Gy irradiation. Shown is the mean quantity ± SEM of
Evans blue (µg) per organ weight (g). *P < .05 compared with corresponding
unirradiated controls. N = 4 to 6 per group. (B) Mice exposed to 0, 0.5, or 1.5 Gy of
irradiation were inoculated with CD45.2 CCR7/CCR9 DKO BM cells plus CD45.1 WT
BM at a 2:1 ratio (106 total cells). Shown is the mean CD45.2 donor chimerism ± SEM of
thymic DP cells after 3 weeks. *P < .05 compared with the control. N = 3 per group. (C)
Top row: CD45.2 WT (left) or PSGL-1−/− (right) BM cells (1.4×107) were adoptively
transferred into unirradiated CD45.1 WT hosts. Shown are representative plots of thymic
DN3 cells 3 weeks after transfer. Bottom row: Mean CD45.2 chimerism ± SEM of BM
granulocytes (left) and thymic DN3 cells (right). *P < .05 compared with the WT control.
N = 5 to 10 per group. (D) Top row: Lethally irradiated BM chimeras were generated
using CD45.2 WT (left) or CD45.2 PSGL-1−/− BM (right) mixed with CD45.1 WT
competitor cells at a 2:1 ratio (2×106 total cells). Shown are representative plots of
thymic DN3 cells 3 weeks after transplant. Bottom row: Mean CD45.2 chimerism ± SEM
of BM granulocytes (left) and thymic DN3 cells (right). *P < .05 compared with the WT
control. N = 5 to 10 per group.
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Figure 4.3 Intrathymic development is not dependent on PSGL-1. Sorted CD45.2 WT
or PSGL-1-/- LMPPs (3x103) were intrathymically injected into sublethally irradiated
CD45.1 WT hosts. Two weeks later, recipient thymi were analyzed by flow cytometry for
the presence of donor cells. Shown is the mean CD45.2 chimerism ± SEM of thymic
DN3 cells in recipient mice. N = 4-5 for each group.
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Figure 4.4 Progenitor homing is profoundly reduced by irradiation conditioning.
(A) Short-term homing assay was performed with unirradiated recipients or recipients
receiving 600 or 900 cGy total body irradiation (TBI). The number of thymic settling
progenitors was calculated using limit dilution analysis. Data are represented as mean ±
s.e.m. (n = 3) Limit of detection (dotted line) is calculated from lowest number of donor
cells that yielded positive results in short-term homing assay of unirradiated mice. (B)
Mice were irradiated at 600 rads or left untreated. Two hours later, 3x105 CD45.1 bone
marrow cells or sorted Flt3+Lin-Kit+ cells were intrathymically injected into recipient
mice. Thymi were analyzed for donor cells by flow cytometry 22 hours later. (n = 3) (C)
106 intrathymically injected donor BM cells were sorted from irradiated or unirradiated
mouse thymi and plated on OP9DL4. Cocultures were analyzed after 10 days. (n = 2)
Representative plots are shown.
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Figure 4.5 Irradiation conditioning of the thymus reduces homing of progenitors.
(A) Short-term homing assay was perfomed with unconditioned recipients or recipients
receiving 900 cGy irradiation to the upper (includes thymus) or lower half (excludes
thymus). Cocultures were analyzed by flow cytometry between two and three weeks
later. (n = 3) (B) Short-term homing assay was performed on unirradiated recipients or
recipients receiving 900 cGy directed irradiation of the thymus (DI). Cocultures were
analyzed between two and three weeks later. (n = 3) (C) Short-term homing assay was
performed on mice two weeks after mice were left unirradiated or irradiated with 900
cGy of directed thymic irradiation. Cocultures were analyzed between two and three
weeks later. (n = 2)
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Figure 4.6 Homing determinants on endothelial cells continue to be expressed after
irradiation. Thymi were harvested from unirradiated mice and mice that had been
irradiated with 600 cGy 24 hours prior. (A) Total thymic cellularity was enumerated.
Enumeration of endothelial cells was determined by flow cytometric analysis of the
CD45-CD31+ population. (n = 3) (B) Endothelial cells were visualized by
immunohistochemistry using an antibody to CD31. (C) P-selectin, (D) ICAM-1, (E)
VCAM-1 expression was determined on CD31+ endothelial cells by flow cytometry.
Shown are histograms gated on unirradiated CD45+ cells (gray), unirradiated CD31+ cells
(solid black line), and irradiated CD31+ (dotted black line). (n = 3) Gating for P-selectin
was established previously with P-selectin knockout mice. Data are represented as mean
± s.e.m. * p<0.05 compared to unirradiated.
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Figure 4.7 p53-dependent loss of epithelial cells correlates with reduced homing
following irradiation. (A) Enumeration of epithelial cells was determined by flow
cytometric analysis of the CD45-EpCam+ TEC population. (n = 3) (B) Short-term homing
assay of WT cells into congenic irradiated WT or p53-deficient recipients. (n = 2)
Representative flow cytometric plots of cocultures are shown.
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Figure 4.8 Chemokines are primarily produced by TECs. Unirradiated thymi were
sorted into CD45-EpCam+ TECs, CD45-CD31+ endothelial cells, and CD45+ cells. (n =
3) Each population was analyzed for (A) CCL19, (B) CCL21, and (C) CCL25 mRNA
expression by qPCR and normalized to GAPDH. CD45-EpCam+ were sorted from
unirradiated mice or mice that had received 600 cGy of irradiation 24 hours prior. (n = 3)
RT-PCR of CCL21, CCL19, and CCL25 expression was normalized to GAPDH and
quantified relative to the unirradiated control.
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Figure 4.9 Chemokine levels on thymic endothelial cells are reduced after
irradiation. (A-B) 10 um sections were taken from frozen thymi of untreated WT, TBI
600 rads (24 hrs), TBI 600 rads (2 wks), and CCL25-deficient mice and stained with
antibodies to CD31 (red) and CCL25 (green). Intensities of cross sections were taken
across blood vessels. (n = 3) Representative microscopy sections are shown. Plot profile
(white arrow) of intensities in each channel was generated in Image J and superimposed.
Data are represented as mean ± s.e.m. * P<0.05 compared to unirradiated.
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Figure 4.8 Continued. Chemokine levels on thymic endothelial cells are reduced
after irradiation.
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Figure 4.10 Pretreatment with CCL21/CCL25 rescues homing to the thymus after
irradiation.
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(A) Bone marrow was incubated with PBS or CCL21 and CCL25 for 30 mins at 37°C.
107 pretreated bone marrow cells were injected into unirradiated recipients or mice that
had received 600 cGy TBI for a short-term homing assay. (n = 3) Representative flow
cytometric plots of cocultures are shown. (B) 100 sorted Flt3+LK cells pretreated with
CCL21 and CCL25 for 30 minutes were grown on OP9D4 in the presence of IL7 and
Flt3. Co-cultures were analyzed by flow cytometry after 10 days. Number of
Thy1+CD25+ cells are shown. (C) Bone marrow was incubated with blocking anti-α4
prior to pretreament or CCL21/CCL25 was washed from the cells following pretreatment
and left for 30 mins at 37°C. After 14 days, thymi was examined for donor reconstitution
by flow cytometry. (n = 3) (D) After 16 days, bone marrow and thymi from PBS or
pretreated groups were examined for total thymocyte numbers and donor reconstitution
by flow cytometry. (n = 3) Data are represented as mean ± s.e.m. * P<0.05 compared to
untreated.
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Figure 4.11 Pretreatment with CXCL12 increases thymic reconstitution. 107 CD45.2
(donor) bone marrow cells were incubated with CXCL12 for 30 mins at 37°C prior to
injection into CD45.1 (host) mice that had been irradiated with 600 rads. After 16 days,
bone marrow was analyzed for donor LSK and the thymus was analyzed for donor and
total cellularity. Data are represented as mean ± s.e.m. * p<0.05 compared to untreated.
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5. CHAPTER V: ACUTE INFLAMMATION REDUCES PROGENITOR
HOMING TO THE THYMUS
5.1 Introduction
Inflammation is part of a complex biological response of vascular tissues to harmful
stimuli such as pathogens or damaged cells; however, both acute and chronic
inflammation can be damaging to tissues (Buckley et al., 2014; Pawelec et al., 2014).
When exposed to inflammatory stimulus, thymocytes apoptose resulting in thymic
involution (Hick et al., 2006; Liang et al., 2013). Intrathymic mechanisms that drive
thymic involution in response to inflammation is poorly understood.
Endotoxemia-induced thymic atrophy is a valuable model to examine the effect of
inflammation on thymopoiesis (Billiard et al., 2011). LPS is the major component of the
outer membrane of Gram-negative bacteria that is recognized by animal immune systems
through activation of toll-like receptor 4 (TLR4). After LPS challenge, the thymic
architecture is severely perturbed and there is loss of distinct cortico-medullary junctions
(Gruver et al., 2009). The output of naïve T cells is substantially reduced immediately
following LPS treatment; however, without additional perturbations acute thymic atrophy
can resolve over time (Gruver and Sempowski, 2008). Other inflammation-inducing
molecules such as polyinosinic:polycytidylic acid (poly I:C), a TLR ligand which is
structurally similar to double-stranded RNA present in some viruses, also induce thymic
atrophy (Dooley and Liston, 2012). Improving our current understanding of LPS-induced
or other inflammation-induced thymic atrophy and recovery may provide novel
therapeutic approaches to ameliorate the damaging effects of inflammation.
In this study, we examine whether thymic function is perturbed following endotoxin
administration to mice. We find that early thymic populations are reduced after acute
inflammatory stimulation. This coincides with a reduction in homing after acute LPS
treatment; however, this is not due to endotoxin-induced thymic epithelial cell loss or
reduced levels of chemokine mRNAs. In addition we find that chronic LPS treatment
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does not reduce the level of recent thymic emigrants, suggesting that thymic function is
left uncompromised by chronic TLR stimulation.
5.2 Results
5.2.1 Homing is reduced following LPS treatment
We first wanted to determine whether inflammation has a lasting effect on thymopoiesis
by examining early thymocyte populations a short period after exposure. Mice received
either PBS, LPS, or poly I:C by a single intraperitoneal injection. We compared these
conditions to mice receiving sublethal irradiation. Two weeks after treatment, the thymus
was analyzed by flow cytometry for ETP and DN2 populations. We found that similar to
irradiation conditioning, LPS and poly I:C both reduced ETP and DN2 populations when
compared to the PBS-treated control (Figure 5.1A)
To determine whether the reduction in early thymocyte populations could be due to a
decrease the number of progenitors that settle the thymus, we performed a short-term
homing assay. 107 CD45.2 bone marrow cells were injected into recipient CD45.1 mice
that had received PBS or LPS intraperitoneally 24 hours prior. 22 hours after bone
marrow injection, the mice were sacrificed and thymocytes were enumerated (Figure
5.1B). Donor cells were isolated from the thymus and plated on OP9DL4 in the presence
of T-inductive conditions. Two weeks later, the cocultures were analyzed and we found
that the cocultures derived from LPS-treated mice did not contain T-lineage cells,
indicating that LPS treatment blocked homing of T-lineage progenitors (Figure 5.1C).
After irradiation conditioning, thymic homing is profoundly reduced likely due to the loss
in chemokine-producing thymic epithelial cells (TECs).(Zhang et al. unpublished) We
therefore examined whether the reduced homing after LPS treatment may be attributed to
the same mechanism; however, when we examined the number of TECs we found that
LPS did not reduce the total number of TEC (Figure 5.2A). We next determined whether
LPS could injure TECs by reducing amount of chemokine production. TECs were sorted
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from PBS or LPS injected mice 24 hours prior and mRNA of chemokines required for
homing were examined. The amount of CCL19, CCL21, and CCL25 were each similar in
TECs from PBS and LPS-treated mice (Figure 5.2B). These data suggest that the total
level of chemokine mRNA production is unaffected by LPS and thus, does not resolve
the question of how progenitor homing is reduced following LPS treatment.
5.2.2 Chronic TLR stimulation does not result in loss of thymic function
We then determined whether chronic LPS treatment affected thymic function long-term.
To label T cells that have recently emigrated from the thymus, we used mice that
contained the functional fusion gene Rag2-GFP knocked-in to the endogenous Rag2
locus resulting in the production of naïve GFP+ T cells that gradually lose expression of
GFP over several weeks (Chung et al., 2001; Monroe et al., 1999). PBS or LPS daily for
28 days and then examined the blood, spleen and thymus after resting the mice for 2
weeks. Consistent with previous reports (Im et al., 2012), we observed increases in the
size and number of cells in the spleen in response to chronic TLR stimulation; however,
there were no changes found in the number of thymocytes (Figure 5.3A). Early
thymocyte populations were comparable between PBS- and LPS-treated mice (Figure
5.3B). In the blood, no differences were observed in either the percentage of CD4 and
CD8 mature T cells or the percentage of recently emigrated T cells within T cell
populations (Figure 5.3C). We were unable to detect any loss in thymic function that can
be attributed to chronic LPS treatment.
5.3 Discussion
Inflammatory responses are essential for control of pathogens and tissue repair, but can
cause collateral damage of tissues (Pawelec et al., 2014). Here, we have shown that
following acute TLR stimulation, homing of progenitors to the thymus is reduced. This is
similar to the effect of irradiation conditioning on homing of progenitors; however,
unlike irradiated thymi, LPS-treated thymi do not exhibit reduction in TECs or reduction
in chemokine mRNA levels. It is likely that LPS-induced vascular damage perturbs
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homing molecules on endothelial cells (Munshi et al., 2002). More experiments are
necessary to determine the cause of LPS-induced reduction of progenitor homing to the
thymus.
We thought to examine whether the thymic function could be damaged by chronic
inflammation; however, our results did not indicate any differences in thymocyte
populations or recently emigrated T cell populations. These data suggest several
possibilities: 1) homing of progenitors may not be reduced by lower levels of LPS
treatment or 2) the thymus can compensate for the loss in homing to the thymus under
chronic TLR stimulation. Chronic LPS treatment does not have any apparent effect on
thymic function in our studies here; however, our model uses young adult mice. The
inflammatory responses of mice do not correlate well with the responses in humans (Seok
et al., 2013). Additionally, chronic inflammation in humans occurs with increased
frequency in the elderly (Franceschi et al., 2000; Michaud et al., 2013). One last caveat is
that the activation of inflammatory pathways through LPS may not resemble a complete
biological response to pathogens. Going forward, the use of different models will be
necessary to reveal the possible role for inflammation to impact thymic function.
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Figure 5.1 Acute LPS treatment reduces homing to the thymus. (A) PBS, Poly I:C, or
LPS was injected into mice via intraperitoneal injection. Another group of mice were
given sublethal (600 cGy) irradiation. After two weeks, thymi were harvested and
analyzed by flow cytometry. ETP and DN2 populations were enumerated. Shown are
means ± SEM. (B) Total thymocytes were enumerated from mice treated with PBS or
LPS 24 hours prior. Shown are means ± SEM. (C) Mice were treated with PBS or LPS
via intraperitoneal injection. 24 hours later, mice were injected with 107 T-depleted
congenically marked bone marrow cells. Donor cells were sorted from the thymus and
plated on OP9DL4. Cocultures were examined by flow cytometry 2 weeks later.
Representative plots are shown.
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Figure 5.2 Chemokine gene expression on TEC after LPS treatment. Mice were
treated with PBS or LPS and thymus was examined 24 hours later. (A) CD45- EpCam+
cells were sorted from the thymus and levels of CCL25, CCL21, and CCL19 mRNA was
measured by qPCR. Shown are the mean ± SEM. (B) CD45- EpCam+ cells were
enumerated. Shown are the mean ± SEM.
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Figure 5.3 Chronic LPS does not reduce numbers of thymocytes or recent thymic
emigrants (RTE). Mice with Rag2-GFP fusion gene knocked-in to the endogenous Rag2
promoter, used to measure RTEs, were treated with PBS or lower dose LPS daily for 28
days. 2 weeks after the last injection, (A-B) thymus, (A) spleen, and (C) blood and
thymus was examined by flow cytometry. Shown are mean ± SEM.
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6.

CHAPTER VI: MATERIALS AND METHODS
Mice
Mice used included C57Bl/6, B6.Ly5SJL mice (National Cancer Institute), PSGL-1-/- mice
(Jackson Laboratory) and CCL25-/- mice (Jackson Laboratory). CCR7-/-CCR9-/- mice
were generated by crossing CCR7-/- and CCR9-/- strains, obtained from The Jackson
Laboratory and Dr. Paul Love (NIH, Bethesda, MD), respectively. Mice with the Rag2GFP fusion gene knocked into the Rag2 endogenous promoter were provided by Taku
Kambayashi. Mice used were 4-10 weeks old. Animal experiments were performed
according to approved protocols of the Office of Regulatory Affairs at the University of
Pennsylvania in accordance with National Institutes of Health guidelines.
Tissue preparation
Bone marrow cell suspensions were cleared of red blood cells (RBCs) using ACK lysis
buffer (Lonza). For cell sorting, bone marrow was enriched for progenitors by incubation
with anti-CD19 and anti-Gr-1 antibodies. Antibody-bound cells were removed with
magnetic beads conjugated to goat anti-rat IgG (QIAGEN). For dissection of thymi for
short-term homing assay, blood lymphocytes were removed from mice through
exsanguination using a heparinized collection tube and intracardiac PBS perfusion.
Thymocytes were prepared as a single-cell suspension by manual dissection with forceps.
For assessment of thymic settling progenitors, thymocytes were enriched for donor cells
through depletion of single-positive and double-positive thymocytes with antiCD4(GK1.5) and anti-CD8(53.6-7). For preparation of TECs and thymic endothelial
cells, dissected thymocytes were incubated in 40 µg/ml Liberase TM (Roche) and 200
µg/ml DNase I (Roche) in HBSS for 30 mins at 37°C with agitation. For enrichment of
TEC and endothelial cells in preparation for cell sorting, samples were depleted of CD4+
and/or CD8+ cells as described above.
Cell preparations, flow cytometry, cell sorting
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BM and thymocytes were collected as previously described (Zlotoff et al., 2010).
Antibodies (Abs) in the Lin cocktail included: anti-B220 (RA3-6B2), anti-CD19 (1D3),
anti-CD11b (M1/70), anti-Gr-1 (8C5), anti-CD11c (HL3), anti-NK1.1 (PK136), anti-Ter119 (Ter-119), anti-CD3 (2C11), anti-CD8α (53.6-7), anti-CD8β (53-5.8), anti-TCRβ
(H57), and anti-γδTCR (GL-3). Additional Abs used included anti-CD45.2 (104), antiCD45.1 (A20), anti-Kit (2B8), anti-Sca1 (D7), anti-Flt3 (A2F10), anti-IL-7Rα (A7R34),
anti-CD25 (PC61.5), anti-CD4 (RM4-5), anti-Thy1.2.(53-2.1) Abs were purchased from
eBioscience, BD Pharmingen, and Biolegend. BM was sorted on a FACSAria II (BD
Biosciences). An LSRII (BD Biosciences) was used for FACS analysis. Dead cells were
excluded through DAPI (4',6-diamidino-2-phenylindole) uptake. Doublets were excluded
through FSC-H by FSC-W and SSC-H by SSC-W parameters. Data were analyzed using
FlowJo software (Tree Star).
Intravenous and intrathymic transfers
For intravenous transfers, T-cell-depleted BM cells were injected retro-orbitally. To
prevent rejection, mice were given 0.1 mg anti-CD4 (GK1.5) by intraperitoneal injection
the day before BMT and every four days thereafter. For intrathymic transfers, 3x103
sorted BM LMPPs or Lin–Kit+Flt3high cells were injected intrathymically (Goldschneider
et al., 1986). For intrathymic injections into sublethally irradiated hosts, a radiation dose
of 6 Gy was used. For BM transplants, host CD45.1 WT mice were lethally irradiated
(9.5 Gy) and inoculated with T-cell-depleted donor BM four to eight hours after
irradiation. Radiation was delivered at an average rate of 36.5 cGy/minute by a Cs-137
source for a total dose of 600 or 900 cGy. Image-guided irradiation of the thymus was
performed with a small animal radiation research platform (SARRP) with the assistance
of Timothy W. Jenkins (Radiation Oncology, University of Pennsylvania).
In vitro culture of thymic progenitor cells
Recipient mice were exsanguinated, perfused with PBS, the thymus was removed and a
single-cell suspension was prepared in (RPMI) 10% fetal bovine serum at 22, 44, or 72
hours after cell transfer. Samples were depleted of CD4 and CD8-expressing thymocytes
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and stained with antibodies to CD45.1, CD45.2 for cell sorting. Donor cells were sorted
and plated onto confluent wells of OP9-DL4 stroma (gift of Juan C. Zúñiga-Pflücker,
University of Toronto), in the presence of 1 ng/mL of IL-7 and 5 ng/mL of Flt3L
(PeproTech). After 10-21 days of culture, donor-derived thymocytes were detected by
flow cytometry using antibodies to CD25 and Thy1. For limit dilution analysis, all donor
cells were sorted, and aliquots of sorted cells were added to 96-well OP9-DL4 cultures.
Plating efficiency of progenitor cells was >70% (Bell and Bhandoola, 2008). Wells
containing a donor-derived T-lineage population (greater than 20 Thy1+CD25+ cells)
were considered positive. The frequency of progenitors in the sorted population was
calculated using L-calc software. Nonspecific cell loss due to depletion (typically 4060%) was estimated by measuring the number of Lin-CD25+ DN3 cells before and after
depletion, using flow cytometry to measure the frequency of DN3 cells combined with
cell counts.
Vascular permeability studies
Mice were irradiated (1.5 Gy or 9.5 Gy) 24 hours before injection of Evans blue (Sigma)
or injected intraperitoneally with 5µg/g LPS (Sigma) 30 minutes after injection of Evans
blue. Mice were intravenously injected with 20µg Evans blue per gram of body weight.
After 2.5 hours, anesthetized animals were exsanguinated and perfused with PBS to clear
intravascular Evans blue. The thymus and one lobe of the lung were removed from each
mouse, weighed, and homogenized in PBS. Evans blue was extracted by formamide for
24 hours at 55°C. Absorbances of extracted Evans blue at 620nm and 740nm were read
on a spectrophotometer (BioRad SmartSpec3000). The concentrations of extracted Evans
blue were calculated as previously described (Wang le et al., 2002).
Tissue fixation and microscopy
Thymi were harvested in PBS and cryosectioned into 20-μm sections by the Cancer
Histology Core (University of Pennsylvania Abramson Cancer Center). Tissues were
fixed in acetone and stained with biotinylated anti-CCL25 (R&D), streptavidin-AF594
(Jackson) and anti-CD31-AF488 (Biolegend). Images were taken with either Zeiss
Axioplan2 or Zeiss LSM NLO/META with assistance from the Cell and Developmental
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Biology Microscopy Core (University of Pennsylvania). Quantification was performed
with ImageJ software on six images for each irradiated and unirradiated thymus. For
quantitative analysis, arrows were drawn perpendicular through each CD31+ vessel
without observing CCL25 fluorescence. Intensity plots were generated and the two peaks
of CD31 fluorescence (representing blood vessel walls) were selected. These plots were
overlaid with the corresponding CCL25 fluorescence intensity plots and the intensities of
CCL25 between the two peaks of CD31 fluorescence were summed. The average
summed intensity of CCL25 fluorescence in CCL25KO thymi was subtracted.
Chemokine pretreatment
107 T-depleted bone marrow or 2x105 sorted Lin-Kit+Sca1+Flt3+ cells were suspended in
MEMα and incubated with 500 ng/ml recombinant murine CCL21 (R&D) and 500 ng/ml
recombinant murine CCL25 (R&D) for 30 mins at 37°C. Media and chemokine cocktail
were removed and cells were resuspended in PBS or OP9 media for intravenous injection
or in vitro culture respectively.

For α4 integrin blockade, anti-α4 (Clone R1-2,

Biolegend) was incubated at 10 µg/ml at 37°C for 15 mins prior to pretreatment.
Inducing inflammatory responses in mice
For acute LPS treatment, 50 µg LPS (0111:B4; Sigma) in 100µl PBS was administered to
mice by intraperitoneal injection. For chronic LPS treatment, daily intraperitoneal
injections of 6 µg LPS in 100 µl PBS was administered over 4 weeks. For Poly I:C
treatment, 100 µg Poly I:C (Sigma) was administered to mice by intraperitoneal injection.
Statistical analysis
For limiting dilution analysis assays, statistical calculations were performed using L-Calc
software. P values were calculated using Microsoft Excel by Student’s t-test or GraphPad
by Fisher’s exact test.
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7. CHAPTER VII: DISCUSSION
7.1 Identifying physiologic progenitor homing to the thymus
The thymic settling progenitor has been difficult to study due to its rarity (Wallis et al.,
1975). Among the populations of bone marrow progenitors, HSC, MPP, LMPP and CLP
each have T lineage potential; however, the identity of the thymic settling progenitor has
remained controversial (Saran et al., 2010; Serwold et al., 2009). In this work, we sought
to resolve this controversy by developing a method that assesses thymic settling
progenitors by their function definition – a cell that traffics to the thymus with T lineage
potential. Using this assay, we have concluded that the efficient thymic settling
progenitors reside within the both LMPP and CLP populations; however homing by more
primitive HSC or MPP were not detected by our assay (Figure 2.2). These results are
consistent with the expression of trafficking molecules important for homing to the
thymus, as discussed in more detail below.
Trafficking of thymic settling progenitors into the thymus is thought to be analogous to
lymphocyte migration into lymph nodes in which trafficking molecules on lymphocytes
interact with ligands on endothelium to mediate rolling, activation, adhesion, and
extravasation (Scimone et al., 2006; Springer, 1994). Previous work has shown that for
the thymus, key trafficking molecules on progenitors and their corresponding ligands on
TECs are PSGL-1 – P-selectin, CCR7 – CCL19/21, CCR9 – CCL25, and LFA1 – VLA4
(Scimone et al., 2006). The expression of CCR7, CCR9, and functional PSGL-1 are
developmentally regulated; present on LMPP and CLP, but not upstream progenitors
(Sultana et al., 2012; Zlotoff et al., 2010). There are, however, many more CCR9expressing or functional PSGL-1-expressing cells in the intravenously injected BM than
the estimate of the number of cells that settle the thymus.(data not shown; Figure 2.3)
Quantification of homing reveals that approximately 1 out of 2300 intravenously injected
LMPP and CLP traffics to the thymus (Figure 2.3). There are two nonexclusive
explanations: 1) many of the progenitors are attracted/absorbed by other tissues or 2)
other yet unidentified molecules further restrict progenitor cell trafficking to a very small
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pool of T-lineage precursors. Understanding the mechanisms that maintain low numbers
of thymic settling progenitors may allow for removal of those limitations in clinical
situations in which promoting thymic settling is beneficial.
In the absence of CCR7 and CCR9, there is residual thymic settling as the mice deficient
in both receptors have ETP (albeit at a very low level), which give rise to a nearly normal
size thymus (Zlotoff et al., 2010). Similarly, the thymi of mice deficient in PSGL-1 have
ETP and a normal size thymus (Rossi et al., 2005b). Together these data suggest that
there may be other chemokines and selectins that compensate for the absence of CCR7,
CCR9, and PSGL-1; however, it is unclear whether these other chemokines contribute to
homing under physiologic conditions. These data exhibit the robustness of progenitor
homing to the thymus, which is probably driven by the evolutionary fitness of
maintaining thymic function in the absence of one or more chemokines.
Our results indicate that the population that settles the thymus is heterogeneous because
cells from both LMPP and CLP populations can home to the thymus. It is unclear which
progenitor population is the larger contributor of thymic settling cells under physiologic
conditions. CLPs express higher levels of both CCR7 and CCR9, and this may translate
to increased efficiency of settling while LMPPs are more primitive progenitors and are
likely to be more potent in generating downstream T lineage cells (Morita et al., 2010).
To determine the relative contribution to thymocyte development, the number of LMPP
and CLP that settle the thymus can be quantified and assessed for the rate of proliferation
and differentiation of single cells. The heterogeneity of thymic settling progenitors also
suggests that the early thymocytes derived from LMPP may play a different role than
those that are derived from CLP. LMPPs have greater myeloid potential and therefore
they likely play a larger role in generating early ETPs that give rise to thymic
granulocytes (De Obaldia et al., 2013; Luc et al., 2012; Wada et al., 2008). It is unclear
whether restricting thymic settling to either LMPP or CLP would alter the resulting
thymic populations.
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For the first time, we have quantified homing of progenitors to the thymus, revealing that
there are approximately 12 thymic settling progenitors in 10 million intravenously
injected bone marrow progenitors that settle within a single day. There are 10 to 15 times
more bone marrow in an entire adult mouse, which equates to a possible 120 to 180
thymic settling progenitors. The actual number of thymic settling progenitors is likely to
be much lower since hematopoietic progenitors do not rapidly emigrate from the bone
marrow to the blood in the steady state (Lai and Kondo, 2007; Perry et al., 2006; Schwarz
and Bhandoola, 2004). It is remarkable that so few thymic settling progenitors expand
into 150-200 million thymocytes in the course of a few weeks. This high level of
proliferation allows for few changes in division to make large shifts in the thymocyte
population. A 10-fold reduction in progenitor homing to the thymus can be compensated
intrathymically with only 3-4 additional divisions. As a result, the thymus does not
require many T lineage progenitors trafficking to the thymus to generate a normal sized
thymus. This would also suggest that there might not be any benefit to increasing the
number of thymic settling progenitors under physiologic conditions; however
understanding the nature and number of thymic settling progenitors may be important to
facilitate T lineage reconstitution under stress conditions. Although the improving thymic
function may not be advantageous in healthy individuals, better thymic function
correlates with increased survival in patients undergoing BMT (Svaldi et al., 2003).
7.2 Thymic dependent T cell reconstitution after BMT
T cells are slow to reconstitute following bone marrow transplant, leaving patients
immunocompromised for a prolonged period (Storek et al., 2004b). T cell numbers
recover by peripheral expansion through homeostatic expansion or thymic output of
native T cells (Alpdogan et al., 2003; Berzins et al., 1998; Dutilh and de Boer, 2003).
Although both mechanisms can improve numerical defects in T cells, thymicindependent recovery results in limited TCR diversity, rendering the cells functionally
inferior to thymic-dependent T lineage reconstitution (Hsieh et al., 2012; Mackall et al.,
1996; Yager et al., 2008). Following BMT, thymic function is thought to be delayed by
several major causes: 1) thymic stromal damage from conditioning, 2) age-associated
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thymic involution, and 3) GvHD during allogeneic transplants (van Den Brink et al.,
2013). To better isolate and understand how conditioning regimens damage T lineage
reconstitution, we used a model of syngeneic BMT in young adult mice in our studies.
Therefore, our results are likely not representative of thymic reconstitution in allogeneic
transplants or in elderly humans with involuted thymi. Despite the absence of GvHD and
involution in our model, we found that T lineage reconstitution is delayed following
irradiation conditioning, which suggests that additional complications would impact
thymus to an even greater extent.
Prior to our studies, the major focus of work in this field as been at the level of the
thymus; however, our results demonstrate that the supply of lymphoid progenitors in the
bone marrow might contribute to delayed T lineage reconstitution. We detected fewer
lymphoid progenitors in the bone marrow as well as the blood after BMT (Figure 3.13.3). These data point to extrathymic impairments delaying T lineage reconstitution,
which could include damages in the bone marrow stromal environment, reduced
mobilization of lymphoid progenitors, and/or impairment in progenitor survival following
BMT. Understanding pre-thymic defects together with intrathymic defects could lead to
more cohesive approaches towards improving T cell reconstitution.
Another defect in T lineage reconstitution was revealed in our studies. Previously, the
thymus was thought to be hyper-receptive to progenitors due to increased donor
engraftment in the thymus found in the weeks following irradiation; however, the
increase in donor engraftment may be due to increased proliferation within the thymus of
rare thymic homing cells rather than a reflection of increased colonization (Foss et al.,
2002). We found that trafficking of bone marrow progenitors from the blood to the
thymus is reduced over 10-fold following irradiation conditioning (Figure 4.2-2.3).
Irradiation resulted in the death of chemokine-producing TECs, likely reducing
chemokine availability to progenitors circulating through the thymic vasculature.
Providing exogenous chemokine ligands prior to intravenous injection restored homing of
progenitors into irradiated thymi, confirming that chemokine signals are limiting after
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irradiation. These results suggest two additions to the Springer model for leukocyte
extravasation (Figure 7.1). First, the number of TECs is important to maintain levels of
chemokine required for efficient homing after irradiation. These results highlight the
importance of regenerating TECs in order to improve T lineage reconstitution. Second,
homing of thymic settling progenitors can be achieved through the remote activation of
chemokine receptors and localized chemokine signal or gradient is not strictly necessary
for homing to the thymus. These data imply that chemokine ligands produced distal from
the thymus could be involved in activation of thymic settling progenitors under
physiologic conditions. Our results additional suggest that we can further exploit the
remote activation of chemokine receptors to drive progenitors into the thymus that do not
normally settle such as HSCs and MPPs (Figure 4.11). These cells are likely to be even
more potent in generating downstream T lineage cells and may improve T lineage
reconstitution to a greater degree than physiologic thymic settling progenitors.
7.3 Future directions
One of the questions remaining is why bone marrow progenitors reconstitute poorly after
BMT limiting the number of potential thymic settling progenitors. There are several
possible mechanisms for this defect that have not yet been explored. First, the bone
marrow niche supporting lymphoid progenitor development or maintenance may be
damaged by irradiation, preventing robust expansion of this population. Lymphoid
progenitors reside in the endosteal niche of the bone dependent on osteoblasts (Ding and
Morrison, 2013). Irradiation may selectively damage osteoblasts, reducing the lymphoid
progenitor niche. Second, the cytokine milieu in the bone marrow after irradiation may
promote the diversion of multipotent progenitors toward the myeloid fate, reducing the
efficiency of lymphoid progenitor development. Exploiting these mechanisms to
increasing the numbers of lymphoid progenitors in the bone marrow may facilitate rapid
reconstitution of the thymus following BMT.
Although we were able to advance our understanding of thymic development and
regeneration using young mice, better models are necessary for future progress. When
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large numbers of progenitors of donor BM are used to reconstitute irradiated mice, the
thymus reaches a normal size within 3 weeks and T cell numbers are recovered (data not
shown); however, in humans receiving autologous BMT, T cells are poorly reconstituted
for over 2 years (Storek et al., 2004a). This suggests that other defects that delay T
lineage reconstitution in humans are not present or resolved more quickly in mice. In
using young adult mice, we are examining thymi that have not become involuted like
those of elderly humans (Ventevogel and Sempowski, 2013); therefore, a more
appropriate model may be aged mice that have involuted thymi prior to transplantation.
Another approach is to use humanized mice in which pieces of human thymus are placed
under the kidney capsule of immunodeficient mice (Ito et al., 2014). We can then
examine how the thymus responds to BMT conditioning regimens and whether TECs and
chemokine ligands are altered after irradiation in the human thymus. Clinical studies are
also necessary to determine if increases in trafficking of progenitors to the thymus could
result in improved T cell regeneration and therefore patient outcomes. Theoretically, this
could be achieved either by intrathymic injections of progenitors or through chemokine
pretreatment of intravenously injected progenitors.
Our focus in these studies was specific to T lineage reconstitution after irradiation
conditioning and BMT; however, there may be additional situations in which defective
homing impacts the generation of T cells. It is unclear whether other conditioning
regimens that are used in patients (such as cyclophosphamide, busulfan, and/or
melphalan) have a similar deleterious impact on homing or T cell reconstitution (data not
shown). If different myeloablative treatments have varying effects on T cell
reconstitution, it may suggest that specific conditioning regimens could be advantageous
for patients. Most conditioning regimens used for BMT induce systemic inflammation,
which has been shown to impact the thymus (Hick et al., 2006; Liang et al., 2013). We
therefore examined whether inflammation can reduce thymic function. Our results
showed a defect in homing after acute LPS treatment; however, chronic LPS treatments
did not impact the number of mature T cells. In these studies, the degree to which homing
was decreased by chronic LPS was not measured; therefore the reduction in homing may
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have been mild and easily compensated intrathymically. The inflammatory responses of
mice do not correlate well with the responses in humans (Seok et al., 2013). Going
forward, the use of different models will be necessary to reveal the possible role of
inflammation in impacting thymic function. Other than BMT, the thymus function may
be important in controlling infection in elderly patients that have chronic inflammation
(Franceschi et al., 2000; Michaud et al., 2013). In conclusion, more work is necessary to
determine whether there are other models of thymic stress in which continuous defective
progenitor homing impact the number of mature T cells that may have clinical
implications in patients.
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Figure 7.1 Schematic of progenitor adhesion model. Our data suggest two additions to
the Springer and Butcher model for cell trafficking. (A) Homing of thymic settling
progenitors can be achieved through the remote activation of chemokine receptors and
localized chemokine signal or gradient is not strictly necessary for homing to the thymus.
(B) The number of thymic epithelial cells is important to maintain levels of chemokine
required for efficient homing after irradiation.
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